vancomycin has been researched along with rifampin in 566 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 104 (18.37) | 18.7374 |
1990's | 93 (16.43) | 18.2507 |
2000's | 144 (25.44) | 29.6817 |
2010's | 175 (30.92) | 24.3611 |
2020's | 50 (8.83) | 2.80 |
Authors | Studies |
---|---|
Branland, P; Granet, R; Kaldapa, C; Krausz, P; Sol, V; Verneuil, B | 1 |
Bye, R; Janso, JE; Maiese, WM; Martínez, E; Mata, R; Morales, G; Singh, MP; Timmermann, B | 1 |
Maiese, WM; Singh, MP; Timmermann, BN; Wächter, G; Woldemichael, GM | 1 |
Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
Clark, NC; Donlan, RM; Dumas, N; Jensen, B; Kohlerschmidt, D; Limberger, RJ; McDougal, LK; Musser, KA; Patel, JB; Shin, DH; Thompson, J; Weigel, LM; Zhu, W | 1 |
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
Frank, KL; Patel, R; Piper, KE; Reichert, EJ | 1 |
Fiett, J; Gniadkowski, M; Grzesiowski, P; Hryniewicz, W; Izdebski, R; Sadowy, E | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Chaiban, G; Dvorak, T; Hachem, R; Hanna, H; Jiang, Y; Raad, I; Reitzel, R; Sherertz, R | 1 |
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Agrawal, B; Desroches, N; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Tse, C | 1 |
Biswas, K; Crick, DC; Dhiman, R; Kurosu, M; Narayanasamy, P | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
Clark, NC; Hageman, J; McDonald, LC; McDougal, LK; Patel, JB; Zhu, W | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Baltch, AL; Bopp, LH; Michelsen, P; Ritz, WJ; Smith, RP | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bowker, KE; Macgowan, AP; Noel, AR | 1 |
Jayaswal, RK; Ledala, N; Pearson, S; Sitthisak, S; Steidl, R; Stephenson, RE; Wilkinson, BJ | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
Adler, B; Al-Hasani, K; Boyce, J; Dunstone, M; Hatfaludi, T | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, H; Chen, M; Du, N; Liu, Y; Niu, J; Shen, E; Wang, H; Ye, H | 1 |
Arhin, FF; Belley, A; Beveridge, T; Harris, R; McKay, G; Moeck, G; Neesham-Grenon, E; Parr, TR | 1 |
Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
Appelbaum, PC; Beachel, L; Caspers, P; Clark, C; Dewasse, B; Ednie, LM; Gaucher, B; Kosowska-Shick, K; Lin, G; McGhee, P; Mert, G; Shapiro, S; Smith, K | 1 |
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Cui, L; Hiramatsu, K; Katayama, Y; Murakami-Kuroda, H | 1 |
Cartabuke, RH; Nguyen, HT; Nguyen, L; Ogwang, S; Singh, A; Wolff, KA | 1 |
Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ | 1 |
Hurdle, JG; Lee, RE; Sun, D; Yendapally, R | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Bavari, S; Bowlin, T; Butler, MM; Gussio, R; Houseweart, C; Lane, D; Moir, DT; Nguyen, T; Opperman, T; Panchal, RG; Peet, NP; Ulrich, RL; Williams, JD | 1 |
Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Gudiol, F; Murillo, O; Pachón, ME; Verdaguer, R | 1 |
Cheung, CM; Firestine, SM; Rybak, MJ; Vooturi, SK | 1 |
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
Amsler, CD; Amsler, MO; Baker, BJ; Kyle, DE; Ma, WS; Maiese, WM; McClintock, JB; Mutka, T; Perman, JA; Singh, MP; Vesley, B; Zaworotko, MJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Biedenbach, DJ; Jones, RN; Putnam, SD; Ross, JE | 1 |
Almela, M; Armero, Y; Cervera, C; del Río, A; Falces, C; García-de-la-Mària, C; Gatell, JM; Jiménez de Anta, MT; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Ninot, S; Soy, D | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Parra-Ruiz, J; Rose, WE; Rybak, MJ; Vidaillac, C | 1 |
Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
Guo, Y; Hu, F; Jacoby, GA; Lin, D; Wang, F; Wang, M; Wu, S; Xu, X; Yan, G; Ye, X; Zhang, Y; Zhu, D | 1 |
Camargo, IL; Cui, L; Fukuda, M; Hiramatsu, K; Hishinuma, T; Isii, T; Neoh, HM; Ochiai, T; Shoji, M; Watanabe, Y | 1 |
Duerink, DO; Fluit, AC; Goessens, WH; Hadi, U; Horst-Kreft, D; Kuntaman, K; Lemmens-den Toom, N; Lestari, ES; Pastink, M; Severin, JA; Snijders, SV; van Belkum, A; van Wamel, W; Verbrugh, HA | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Berrue, F; Haltli, B; Kerr, RG; McCulloch, MW | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Banerjee, B; Cushman, M; Franzblau, SG; Ghafoor, A; Hamed, MI; Lv, W; Mesecar, AD; Molland, KL; Seleem, MN; Wan, B | 1 |
Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
Antunes, NT; Boudreau, MA; Chang, M; Ding, D; Lastochkin, E; Leemans, E; Lichtenwalter, K; Mobashery, S; O'Daniel, PI; Peng, Z; Pi, H; Schroeder, VA; Song, W; Spink, E; Suckow, MA; Testero, SA; Vakulenko, S; Wolter, WR | 1 |
Athanassopoulos, CM; Dinos, GP; Garnelis, T; Kalpaxis, DL; Kostopoulou, ON; Kournoutou, GG; Leotsinidis, M; Magoulas, GE; Papaioannou, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blair, PM; Mitchell, DA; Molloy, EM; Tietz, JI | 1 |
Lynch, AS; Ma, Z | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Agrawal, B; Garg, S; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC | 1 |
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
Dong, Y; Golla, RM; Lushnikova, T; Wang, G; Wang, X | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Benková, M; Hrabálek, A; Karabanovich, G; Kavková, V; Klimešová, V; Konečná, K; Macháček, M; Němeček, J; Roh, J; Soukup, O; Stolaříková, J; Sychra, P; Vávrová, K | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
Berscheid, A; Brötz-Oesterhelt, H; Chaidir, C; Daletos, G; Hartmann, R; Kalscheuer, R; Kassack, MU; Mokhlesi, A; Proksch, P; Rehberg, N; Stork, B; Stuhldreier, F; Sureechatchaiyan, P; Wesselborg, S; Wex, KW | 1 |
Abdelghany, TM; Elkabbany, AH; Ghiaty, A; Hagras, M; Hegazy, YA; Mayhoub, AS; Mohammad, H; Seleem, MN | 1 |
Abutaleb, NS; Bayoumi, A; Ghiaty, A; Hagras, M; Kotb, A; Mayhoub, AS; Mohammad, H; Seleem, MA; Seleem, MN | 1 |
Abouelhassan, Y; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Kim, YS; Luesch, H; Tan, H | 1 |
Abouzid, KA; Abutaleb, NS; ElAwamy, M; Hagras, M; Hussien, A; Mayhoub, AS; Mohammad, H; Seleem, MN; Serya, RAT; Taher, AT | 1 |
Borra, RS; Chopra, S; Das, S; Dasgupta, A; Gatadi, S; Gour, J; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
Bellamacina, C; Benton, BM; Bojkovic, J; Fu, J; Karur, S; Lapointe, G; Lee, PS; Liu, A; Madera, AM; McDowell, L; McKenney, D; Morris, L; Osborne, C; Rico, A; Shu, W; Simmons, RL; Sweeney, ZK; Thompson, K; Tjandra, M; Tonn, GR; Uehara, K; Xie, L; Xu, W; Yifru, A | 1 |
Abdeen, S; Ambrose, AJ; Chapman, E; Hoang, QQ; Johnson, SM; Kunkle, T; Park, Y; Ray, AM; Salim, N; Stevens, M; Victorino, J | 1 |
Eswaran, S; Narayanan, S; Shivarudraiah, P; Shruthi, TG; Subramanian, S | 1 |
Cai, S; Fang, Z; Guo, Q; Huang, X; Li, Y; Lin, H; Lu, YJ; Sun, N; Tang, Z; Wong, KY; Wong, WL; Yuan, W | 1 |
Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
Abutaleb, NS; Elsebaei, MM; Gowher, H; Mayhoub, AS; Michie, AR; Mohammad, H; Moustafa, MM; Norvil, AB; Samir, A; Samy, H; Seleem, MN | 1 |
Barua, N; Blanchard, N; Chan, PK; Chan, ST; Hanquet, G; Ip, M; Lin, L; Ma, C; Qiu, Y; Shek, TL; Tsang, TF; Yang, X; Zhang, Y; Zuo, Z | 1 |
Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
Gou, S; He, Y; Liu, H; Liu, T; Ni, J; Wang, L; Yao, J; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
Duan, X; Huang, M; Kong, B; Nian, S; Peng, Y; Qin, J; Tan, X | 1 |
Artsimovitch, I; Chan, ST; Chu, AJ; Harper, R; Ip, M; Ma, C; Sambir, M; Shek, TL; Yang, X; Ye, J; Zhang, Y; Zuo, Z | 1 |
Abutaleb, NS; Alhashimi, M; Kassab, AE; Mayhoub, AS; Mohamed, KO; Seleem, MN; Shahin, IG; Taher, AT | 1 |
Artsimovitch, I; Chan, ST; Chu, AJ; Harper, R; Lin, L; Ma, C; Xiao, M; Yang, X; Ye, J; Zuo, Z | 1 |
Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
Alexandrova, LA; Avdanina, DA; Boykova, YV; Efimenko, TA; Efremenkova, OV; Glukhova, AA; Jasko, MV; Karpenko, IL; Kochetkov, SN; Kolonitskaya, DP; Kost, NV; Negrya, SD; Nuraeva, GK; Shevchenko, OV; Solodinin, AP; Solyev, PN; Volkov, IA; Zhgun, AA | 1 |
Alam, MA; Basnakian, AG; Frangie, MM; Gilmore, DF; Hansa, RK; Khan, MMK; Savenka, AV; Shelton, RS; Shuttleworth, SL; Smeltzer, MS | 1 |
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
Chen, W; Ma, S; Song, D; Zhang, N; Zhang, P; Zhang, S | 1 |
Beniddir, MA; Bernadat, G; Fontaine, V; Fouotsa, H; Gallard, JF; Lannang, AM; Le Pogam, P; Leblanc, K; Meyer, F; Mkounga, P; Nkengfack, AE; Poupon, E; Rharrabti, S; Vanheuverzwijn, J; Zhou, Z | 1 |
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C | 1 |
Abugazleh, MK; Alam, MA; Ali, H; Gilmore, D; Raj Kc, H; Roy, S; Saleh, I | 1 |
Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
Abuelkhir, AA; Abutaleb, NS; Attia, AS; Elsebaie, MM; Liang, HW; Mayhoub, AS; Nour El-Din, HT; Seleem, MN | 1 |
Dewangan, RP; Ghosh, JK; Gupta, A; Habib, S; Mitra, K; Pant, G; Verma, DP; Verma, NK | 1 |
Guo, XC; Huang, XH; Lu, YJ; Ser, HL; She, MT; Sun, N; Wong, WL; Zhang, YH; Zheng, BX; Zhong, DX | 1 |
Bernhardt, PV; Capon, RJ; Khalil, ZG; Salim, AA; Wu, T | 1 |
Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
Eichenwald, HF; McCracken, GH | 1 |
Crossley, K; Faville, RJ; Kaplan, EL; Quie, PG; Sabath, LD; Zaske, DE | 1 |
Aruffo, JF; Bradshaw, MW; Ein, ME; Heerema, MS; Smith, NJ; Williams, TW | 1 |
Fowst, G; Nessi, R | 1 |
Donta, ST; Massanari, RM | 1 |
Lin, MY; Sheagren, JN; Tuazon, CU | 1 |
Archer, GL; Haywood, HB; Tenenbaum, MJ | 1 |
Daneo-Moore, L; Mattingly, SJ; Shockman, GD | 1 |
Anderson, SE; Brown, MS; Chabner, BA; Hande, KR; Levine, AS; MacLowery, JD; Schulman, CB; Witebsky, FG | 1 |
Finegold, SM | 1 |
Johnson, ML; Sande, MA | 1 |
Barakett, V; Burghoffer, B; Delisle, F; Guidet, B; Lesage, D; Offenstadt, G; Petit, JC; Richard, G; Vergez, P | 1 |
Chuard, C; Herrmann, M; Lew, DP; Vaudaux, P; Waldvogel, FA | 1 |
Gaub, J; Gutschik, E; Lundgren, JD; Røder, B; Vestbo, J | 1 |
Auckenthaler, R; Chuard, C; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
Fromm, BS; Levine, DP; Reddy, BR | 1 |
Castelnovo, C; De Vecchi, A; Guerra, L; Ponticelli, C; Scalamogna, A | 1 |
Bacon, AE; Fekety, R; Holloway, WJ; McGrath, S | 1 |
Carmichael, DJ; Rao, GG; Short, A | 1 |
Auckenthaler, R; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
Bandyk, DF; Edmiston, CE; Gohr, C; Krepel, C; Schmitt, DD; Seabrook, GR; Towne, JB | 1 |
Boyer, G; Darbas, H; Jean-Pierre, H; Rauturier, M; Rivière, M | 1 |
Matsumoto, K; Nagatake, T | 1 |
Simon, M; Simon, VC | 1 |
Kanno, H | 1 |
Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O | 1 |
Hessen, MT; Kaye, D; Pitsakis, PG | 1 |
Bhana, RH; Coovadia, YM; Haffejee, I; Johnson, AP; Marples, RR | 1 |
Gagnon, RF; Prentis, J; Richards, GK | 1 |
Marks, J; Paull, A | 1 |
Gagnon, RF; Harris, A; Obst, G; Prentis, J; Richards, GK | 1 |
Pohlod, DJ; Saravolatz, LD; Somerville, MM | 1 |
Waldvogel, FA | 1 |
Arioli, V; Berti, M; Candiani, G | 1 |
Klastersky, J; Van der Auwera, P | 1 |
Boscia, JA; Galetto, DW; Kaye, D; Kobasa, WD | 1 |
Carper, HT; Mandell, GL; Sullivan, GW | 1 |
Durgham, SM; Ishag, AH; Shibl, AM | 1 |
Joly, P; Van der Auwera, P | 1 |
Holder, CD | 1 |
Liu, S; Meyer, RD | 1 |
Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
Falkiner, FR; Jones, L; Keane, CT; Mooney, D; Moorhouse, EC; Mulvihill, TE | 1 |
Libertin, CR; Stein, DS | 1 |
Caillon, J; Dellamonica, P; Drugeon, HB | 1 |
Cohen, J; Ferreira, AC | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Moosdeen, F; Raimondi, A; Williams, JD | 1 |
Feingold, DS; Wagner, RF | 1 |
Goetz, A; Hanchett, J; Rihs, JD; Smith, PB; Wagener, M; Yu, VL; Zuravleff, JJ | 1 |
Buggy, BP; Fekety, R; Silva, J | 1 |
Henry, NK; McConnell, ME; Rouse, MS; Whitesell, AL; Wilson, WR | 1 |
Auger, F; Hansen, SL; Standiford, HC; Tatem, BA; Walsh, TJ | 1 |
Bitar, CM; Bradshaw, TJ; Dalton, HP; Lamb, VA; Mayhall, CG; Spadora, AC | 1 |
Bourgault, AM; Bryan, L; Harding, GJ; Henry, DA; Hoban, DJ; Horsman, GB; Marrie, T; Smith, JA; Turgeon, P | 1 |
Konícek, J; Konícková-Radochová, M; Rytír, V | 1 |
Andrassy, J; Luria, S; Persky, L; Porter, A | 1 |
Brewer, JH; Hanson, EJ; MacGee, E; Osborn, JS; Sharp, S | 1 |
Buccini, FJ; Cherubin, CE; Eng, RH; Smith, SM | 1 |
Pankey, GA; Valainis, GT | 1 |
Aldridge, KE | 1 |
Lin, TY; McCracken, GH; Olsen, K; Sato, K; Weintrub, L | 1 |
Colebunders, R; Pattyn, S; Snoeck, J; Ursi, JP | 1 |
Rouan, MC | 1 |
Eichenwald, HF | 1 |
Borges, LF; Chapman, PH | 1 |
Klastersky, J; Legrand, JC; Meunier-Carpentier, F; Thys, JP; Van der Auwera, P | 1 |
Ho, JL; Klempner, MS | 1 |
Bayer, AS; Lam, K | 1 |
Bryant, RE; Chamovitz, B; Gilbert, DN; Hartstein, AI | 1 |
Babany, G; Benhamou, JP; Bernuau, J; Danan, G; Degott, C; Pessayre, D; Rueff, B; Trunet, P | 1 |
Altmann, G; Bogokovsky, B | 1 |
Chen, NC; Gaafar, HA; Hipp, SS; Lawton, WD | 1 |
Waddell, AD; Walsh, WT; Wisseman, CL | 1 |
Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
Gonçalves, AJ; Moreira, AS; Suzuki, LE | 1 |
Gombosuren, T; Jezek, Z; Mingir, G; Rusinko, M | 1 |
Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
Di Nola, F | 1 |
Durack, DT; Petersdorf, RG | 1 |
Finegold, SM; Nastro, LJ | 2 |
Lerner, PI | 1 |
von Oldershausen, HF | 1 |
Sanford, JP; Swenson, RM | 1 |
Hohenegger, M; Hromadka, A | 1 |
Olson, LC; Vichyanond, P | 1 |
Debbia, E; Schito, GC; Varaldo, PE | 2 |
Bodey, GP; Fainstein, V; Jadeja, L; LeBlanc, B | 1 |
Miller, H; Tuazon, CU | 1 |
Brumfitt, W; Dixson, S; Hamilton-Miller, JM | 1 |
Everett, ED; Strausbaugh, LJ | 1 |
Kirby, WM | 1 |
Ferraris, R; Nahum, M; Pesce, L; Poloniato, G | 1 |
Archer, G; Bornholm, J; Yu, VL; Zuravleff, JJ | 1 |
Watanakunakorn, C | 2 |
Chang, DS; Lash, PR; Lowy, FD | 1 |
Bayer, AS; Morrison, JO | 1 |
Garau, J; Liñares, J; Martín, R; Murgui, L; Perez, JL | 1 |
Walker, CN | 1 |
Foldes, M; Munro, R; Shanker, S; Sorrell, TC; Toohey, M | 1 |
Norden, CW; Shaffer, M | 1 |
Morris, JG; Tenney, JH | 1 |
Ersgaard, H; Friis, H; Hoffmann, S; Justesen, T | 1 |
Andriole, VT; Pachner, A; Root, RK; Ryan, JL | 1 |
Lowy, FD; Steigbigel, NH; Wexler, MA | 1 |
Eckels, DD; Gershwin, ME; Scharre, KA | 1 |
Mandell, GL; Moorman, DR; Peacock, JE; Wenzel, RP | 1 |
Harvey, K; Pavillard, R | 1 |
Mikawa, M; Nakamura, S; Nakashio, S; Nishida, S; Okumura, S; Yamakawa, K | 1 |
Mandell, GL; Moorman, DR; Peacock, JE | 1 |
Connors, JM | 1 |
Tisone, JC; Watanakunakorn, C | 1 |
Crossley, KB; Rotschafer, J; Solliday, J; Tofte, RW | 1 |
Guerriero, JC; Watanakunakorn, C | 1 |
Corrado, ML; Cummings, M; Gombert, ME; Landesman, SH; Melvin, ET; Stein, SC | 1 |
Dusehu, E; Preux, MC; Veyssier, P | 1 |
Archer, GL; Johnston, JL; Vazquez, GJ | 1 |
Lundstrom, TS; Sobel, JD | 1 |
Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
Bayston, R | 1 |
Walker-Renard, P | 1 |
Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
Chambers, HF; Kartalija, M; Sande, M | 1 |
Caillon, J; Drugeon, HB; Juvin, ME | 1 |
Chan, EC; Klitorinos, A; Qiu, YS; Rahal, MD; Siboo, R | 1 |
Friedland, IR; McCracken, GH; Paris, M; Shelton, S | 1 |
Echávarri, B; Marco, ML; Remacha, A | 1 |
Gibson, LE; Kuechle, MK; Leiferman, KM; Maynard, B; Peters, MS; Stegemeir, E | 1 |
Sanford, JB | 1 |
Flanigan, MJ; Hochstetler, LA; Langholdt, D; Lim, VS | 1 |
Pascual, A; Perea, EJ; Ramirez de Arellano, E | 1 |
Chuard, C; Lew, DP; Schaad, HJ; Vaudaux, P; Waldvogel, FA | 1 |
Branchereau, A; Magnan, PE; Raoult, D; Seyral, P | 1 |
Hickey, SM; McCracken, GH; Olsen, KD; París, MM; Shelton, S; Uscher, MI | 1 |
Dunne, WM; Kaplan, SL; Mason, EO | 1 |
Gagnon, RF; Richards, GK | 1 |
John, CC | 1 |
Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J | 1 |
Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
Johnson, CC; Levison, ME; Livornese, LL; Osborne, AJ; Pitsakis, PG; Whitman, MS; Zausner, A | 1 |
Kaplan, SL; Mason, EO; Ou, CN; Tan, TQ | 1 |
Keller, E | 1 |
Budka, H; Halonen, P; Kalimo, H; Marttía, R; Nikoskelainen, J; Oksi, J; Peltonen, R; Salomaa, P; Viljanen, MK | 1 |
Robinson, EN | 1 |
Barakett, V; Delisle, F; Lesage, D; Petit, JC; Vergez, P | 1 |
Bradley, JS; Friedland, IR; Klugman, KP | 1 |
Cervia, JS; Dunn, AM; Noel, GJ; Stavola, JJ; Tizer, KB | 1 |
Bodey, GP; Darouiche, R; Hachem, R; Raad, I; Sacilowski, M | 1 |
McCracken, GH; París, MM; Ramilo, O | 1 |
Domingue, G; Efstratiou, A; George, RC; Johnson, AP; Speller, DC; Warner, M | 1 |
Goodson, M; Humphrey, TJ; Lazim, Z; Rowbury, RJ | 1 |
Daoud, EG; Flexner, C; Goodman, SN; Hartert, TV; Heldman, AW; Kowalski, TE; Lietman, PS; Petty, BG; Pompili, VJ; Ray, SC; Sisson, SD; Tidmore, WC; vom Eigen, KA | 1 |
Blecker, DL; Ferraro, AL; Mortensen, JE; Phengvath, C | 1 |
Douglas, RA; Nairus, JG; Richman, JD | 1 |
Cabellos, C; Liñares, J; Tuban, F | 1 |
Barreiro Casal, G; Cilleruelo Ortega, MJ; García López, M; Martín Fontelos, P; Mellado Peña, MJ; Pérez Jurado, ML; Villota Arrieta, J | 1 |
Aoki, K; Asakura, T; Furuta, S; Tadokoro, M; Tanaka, H | 1 |
Palmer, SM; Rybak, MJ | 1 |
Beck, T; Darouiche, RO; Isiklar, ZU; Landon, GC | 1 |
Bronze, MS; Pallera, A; Schaberg, DR; Whitby, S | 1 |
Hanberger, H; Nilsson, LE; Svensson, E | 1 |
Branley, J; Gottlieb, T; Wolfson, C | 1 |
Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
Garcia, R; Raad, I | 1 |
Calderaro, A; Cattani, P; Chezzi, C; Dettori, G; Grillo, R; Spinetti, AP; Storchi Incerti, S | 1 |
Bryskier, A; Capper, T; Klugman, KP | 1 |
Bradley, JS; Scheld, WM | 1 |
Houlihan, HH; Mercier, RC; Rybak, MJ | 1 |
Akram, S; Campos, JM; Donkersloot, JA; Keith, JM; Pikis, A; Rodriguez, WJ | 1 |
Antony, SJ | 2 |
Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
Bouza, E; Muñoz, P | 1 |
Canawati, HN; Montgomerie, JZ; Schick, DG | 1 |
Tuohy, M; Washington, JA | 1 |
Fallgren, C; Ljungh, A; Petersson, AC; Utt, M; Wadström, T | 1 |
Di Pentima, MC; Kaplan, SL; Mason, EO | 1 |
Donabedian, H; Kaw, M; O'Donnell, ED; Talanin, NY; Zaher, A | 1 |
Blatter, M; Frei, R; Ochsner, PE; Widmer, AF; Zimmerli, W | 1 |
Matsumura, S; Simor, AE | 1 |
Paterson, DL; Taylor, SE; Yu, VL | 1 |
Goëau-Brissonnière, O; Leflon, V; Letort, M; Nicolas, MH | 1 |
Aeschlimann, JR; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
Clarke, R; Panigrahi, H; Qamruddin, A; Taylor, M | 1 |
Beuth, J; Pulverer, G; Schierholz, JM | 1 |
Hamilton-Miller, JMT; Shah, S | 1 |
Bergh, K; Løseth, K; Persen, L; Witsø, E | 1 |
Jain, S; Kerr, KG; Reynolds, GW; Sandoe, JA | 1 |
Beck, K; Müller, M; Schäfer, U | 1 |
Klugman, KP; Madhi, SA | 1 |
Bingen, E; Doit, C; Fitoussi, F; Geslin, P | 1 |
Akpinar, S; Alparslan, M; Demirörs, H; Isiklar, ZU; Tandogan, RN | 1 |
Gang, RK; Lari, AR; Mokaddas, E; Sanyal, SC | 1 |
Kang-Birken, SL | 1 |
Bottura, P; Capra, R; Maggiolo, F; Migliorino, M; Pravettoni, G; Suter, F | 1 |
Burnie, J; D'arcy, S; Gottardello, P; Hodgetts, S; Jiman-Fatami, A; Matthews, R | 1 |
Schlech, WF | 1 |
Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
Guérin, JM | 1 |
Bandera, A; Degli Esposti, A; Ferrario, G; Franzetti, F; Gori, A; Marchetti, G; Rossi, MC; Tocalli, L | 1 |
Humphrey, TJ; Jones, SM; Lappin-Scott, H; Morgan, M | 1 |
Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A | 1 |
Araj, GF; Zouain, MG | 1 |
Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
Bergh, K; Kolmannskog, S; Skogen, PG | 1 |
Ahmad, A; Dick, D; Hullin, MG; Skinner, GR; Zafar, A | 1 |
Holmes, AH; Knox, KL | 1 |
Carty, SM; Cotter, RJ; Lin, S; Raetz, CR; Vorachek-Warren, MK | 1 |
Cabellos, C; Fernández, A; Gudiol, F; Liñares, J; Martínez-Lacasa, J; Martos, A; Tubau, F; Viladrich, PF | 1 |
Ameur, N; Bléton, R; Crémieux, AC; Feger, C; Ismael, F; Lemaitre, F; Massias, L; Muller-Serieys, C; Saleh-Mghir, A | 1 |
Harrington, G; Russo, P; Spelman, D; Wesselingh, S | 1 |
Schoepen, Y; Staerman, F | 1 |
Ford-Jones, EL; Halperin, SA; Kellner, JD; Law, B; Le Saux, N; Lebel, MH; Moore, D; Scheifele, DW; Vaudry, W | 1 |
Choudhury, A; Guha, A; Roy, MK; Unni, BG | 1 |
Grohs, P; Gutmann, L; Kitzis, MD | 1 |
Barbé, G; Bercion, R; Boucaud-Maitre, Y; Boyer, M; Carricajo, A; Célard, M; Chomarat, M; Clergeau, P; Croizé, J; Delubac, F; Fèvre, D; Fredenucci, I; Fuhrmann, C; Gilles, Y; Gravagna, B; Helfre, M; Lelièvre, H; Letouzey, MN; Mandjee, A; Marchal, MF; Marthelet, P; Meley, R; Perrier-Gros-Claude, JD; Reverdy, ME; Ros, A; Roure, C; Sabot, O; Smati, S; Thierry, J; Tixier, A; Tous, J; Verger, P; Zaoui, E | 1 |
Drinkovic, D; Knight, D; Morris, AJ; Pottumarthy, S | 1 |
Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A | 1 |
Bugnon, D; Caillon, J; Donnio, PY; Jacqueline, C; Le Mabecque, V; Miegeville, AF; Potel, G | 1 |
Cha, R; Rybak, MJ | 1 |
Balaban, N; Cirioni, O; D'Amato, G; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Gov, Y; Kamysz, W; Lukasiak, J; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G | 1 |
Jin, JH; Jung, SI; Kim, S; Kim, SW; Kim, YS; Kobayashi, H; Lee, JY; Oh, WS; Peck, KR; Song, JH | 1 |
Appelbaum, PC; Bozdogan, B; Chaitram, J; Clark, N; Jevitt, L; Killgore, G; McAllister, S; McDougal, LK; O'Hara, CM; Patel, JB; Tenover, FC; Weigel, LM | 1 |
Aktaş, E; Ayyildiz, A; Ertek, M; Parlak, M; Yazgi, H | 1 |
Bak, N; Charles, PG; du Cros, P; Fuller, A; Grabsch, EA; Grayson, ML; Howden, BP; Hurley, J; Johnson, PD; Korman, TM; Mayall, BC; Morris, AJ; Read, K; Roberts, SA; Robson, J; Ward, PB | 1 |
Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E | 1 |
Crusius, S; Leber, W; Petzsch, M; Reisinger, EC; Westphal, B | 1 |
Avila-Agüero, ML; Huertas, E; Ulloa-Gutierrez, R | 1 |
Jung, SI; Kiem, S; Kim, SW; Lee, H; Lee, NY; Oh, WS; Peck, KR; Song, JH | 1 |
Altinörs, N; Atalay, B; Caner, H; Ergin, F; Teksam, M | 1 |
Barker, TA; Clarke, B; Denley, H; Grötte, GJ; Kadir, IS | 1 |
Bhaila, I; Ceasar, H; Hamill, RJ; Hulten, K; Lu, MY; Musher, DM; Shelburne, SA | 1 |
Brian, SR; Kimbrough, RC | 1 |
Bregenzer, T; Flueckiger, U; Francioli, P; Genné, D; Harbarth, S; Jacobs, F; Lew, DP; Petignat, C; Schockmel, G; Schrenzel, J; Zimmerli, W | 1 |
Di Rosa, R; Donelli, G; Francolini, I; Occhiaperti, L; Piozzi, A; Ruggeri, V | 1 |
Wegner, DL | 1 |
Calhoun, JH; Lazzarini, L; Li, F; Stevens, CM; Yin, LY | 1 |
Arnold, FW; Wojda, B | 1 |
Chiodo, F; Manfredi, R; Sabbatani, S | 1 |
Baek, DH; Chung, MJ; Ha, NJ; Kang, BY; Kang, JY; Kim, K; Kim, SD; Shin, EA; Yim, DS; Yun, JH | 1 |
Buke, C; Buke, M; Sipahi, OR; Suntur, BM; Yurtseven, T | 1 |
Cabellos, C; Domenech, A; Fernández Viladrich, P; Gudiol, F; Liñares, J; Ribes, S; Taberner, F; Tubau, F | 1 |
Benum, P; Bergh, K; Persen, L; Witsø, E | 1 |
Gkiatas, K; Kararizos, G; Kararizou, E; Likomanos, D; Markou, I; Triantafyllou, N; Vassilopoulos, D; Zalonis, I; Zambelis, T | 1 |
Gordon, D; Ju, O; Woolley, M | 1 |
Adali, F; Baltalarli, A; Goksin, I; Onem, G; Ozcan, V; Sacar, M; Sacar, S; Turgut, H | 1 |
Bet, PM; Debets-Ossenkopp, YJ; Kruse, AJ; Peerdeman, SM | 1 |
Boger, MS; Collins, CA; Mason, L; Raad, II; Sherertz, RJ | 1 |
Jeyaratnam, D; Kearns, A; Klein, J; Reid, C | 1 |
Healy, DG; Wood, AE | 1 |
Bertha, G; Grisold, A; Krause, R; Laferl, H; Smolle, KH; Szell, M; Wenisch, C | 1 |
Bruckner, DA; Deville, JG; Hinnebusch, C; Nielsen, K; Rowlinson, MC | 1 |
Brown, KR; Edmiston, CE; Goheen, MP; Johnson, CP; Lewis, BD; Seabrook, GR; Towne, JB | 1 |
Ariza, J; Cabellos, C; Doménech, A; Garcia, A; Gudiol, F; Murillo, O; Tubau, F | 1 |
Degraeuwe, PL; Neef, C; Pullen, J; Stolk, LM; van Tiel, FH; Zimmermann, LJ | 1 |
Cantón, E; Colombo Gainza, E; Gil Brusola, A; Gobernado, M; Ortiz Estévez, R; Sahuquillo Arce, JM | 1 |
Borbone, S; Campanile, F; Falcone, M; Giannella, M; Stefani, S; Venditti, M | 1 |
Chen, YH; Dickerman, RD; Kattner, KA; Noel, J; Seibly, JM; Stevens, QE | 1 |
Atmar, RL; Daver, NG; Giordano, TP; Reitman, CA; Shelburne, SA; Stager, CE; White, AC | 1 |
Bernis, C; de Lorenzo, A; Diego, G; Sánchez Tomero, JA | 1 |
Hassoun, A | 1 |
Houck, HJ; Rand, KH; Silverman, JA | 1 |
Chan, TM; Lai, KN; Tang, SC; Tse, KC | 1 |
Wu, J | 1 |
Bruce, D; de Lencastre, H; Mwangi, MM; Myers, E; Richardson, P; Rubin, E; Sieradzki, K; Siggia, ED; Tomasz, A; Wu, SW; Zhou, Y | 1 |
Ferrieri, P; Harker-Murray, P; Lee, AB; Schleiss, MR; Tolar, J | 1 |
Yamaoka, T | 1 |
Broekhuizen, CA; de Boer, L; Jones, CD; Quadir, S; Schipper, K; Vandenbroucke-Grauls, CM; Zaat, SA | 1 |
Batard, E; Caillon, J; Hamel, A; Jacqueline, C; Potel, G | 1 |
Abughali, N; Hall, GS; Kumar, D; Kumar, ML; Tuohy, M; Yee-Guardino, S | 1 |
Bennett, JW; Holmes, RL; Jorgensen, JH; Murray, CK; Patterson, JE | 1 |
Adolph, E; Aepinus, C; Petzsch, M; Podbielski, A; von Eiff, C | 1 |
Al-Hindi, MY; Soraisham, AS | 1 |
Adamis, T; Baxevanos, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Koutoukas, P; Pelekanou, A; Skiadas, I; Tsaganos, T; Tzepi, I | 1 |
Becket, E; Bui, A; Hong, J; Kim, K; Liu, A; Miller, JH; Sitz, D; Solaimani, P; Tamae, C; Tran, KP; Yang, H | 1 |
Blanchemain, N; Chai, F; Haulon, S; Hildebrand, HF; Kirkpatrick, CJ; Krump-konvalinkova, V; Laurent, T; Martel, B; Morcellet, M; Neut, C | 1 |
Baratz, M; Ehrlich, GD; Gahlot, V; Johnson, S; Kathju, S; Lasko, LA; Nistico, L; Stoodley, P | 1 |
Busscher, HJ; Engelsman, AF; Nejadnik, MR; Norde, W; Saldarriaga Fernandez, IC; van der Mei, HC | 1 |
Manzur, A; Pujol, M; Suárez, C; Tubau, F | 1 |
Poppens, PT; Rose, WE | 1 |
Adochitei, A; Duez, JM; Neuwirth, C; Péchinot, A; Siebor, E; Sixt, N | 1 |
Boone, TB; Darouiche, RO; Mansouri, MD | 1 |
Amari, Y; Fujino, T; Mohri, M; Noma, M; Yamamoto, H | 1 |
Beltrand, E; Fayad, G; Legout, L; Leroy, O; Senneville, E | 1 |
Cabellos, C; Doménech, A; Force, E; Gudiol, F; Ribes, S; Taberner, F; Tubau, F; Viladrich, PF | 1 |
LaPlante, KL; Woodmansee, S | 1 |
Brown, SM; Fanning, WL; Raflo, GT | 1 |
Akduman, D; Aktaş, E; Aydemir, H; Bektaş, S; Büyükateş, M; Celebi, G; Doğan, SM; Keskin, A; Oztoprak, N; Pişkin, N | 1 |
Baddour, LM; Fadel, HJ; Steckelberg, JM; Tleyjeh, IM; Wilson, WR | 1 |
Deresinski, S | 1 |
Mazer, MA; Ramsey, KM | 1 |
Choi, IS; Chung, JW; Han, SY; Ho Choi, S; Hong, SB; Jung, YJ; Kim, MN; Kim, NJ; Kim, WD; Koh, Y; Lim, CM; Yun, SC | 1 |
Amir, J; Bilavsky, E; Dagan, R; Keller, N; Porat, N; Shouval, DS; Sivan, Y | 1 |
Angelou, AS; Christidou, P; Diamantidis, MD; Ifantidou, AM; Papa, A; Pentilas, D; Tseliki, G | 1 |
Hsueh, PR; Hung, YL; Lee, PI; Lin, SH; Liu, WL | 1 |
Banaszkiewicz, A; Brazier, JS; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; van Belkum, A; Wultańska, D | 1 |
Kotulová, D; Slobodníková, L | 1 |
Hsueh, PR; Lai, CC; Lin, SH; Tan, CK | 1 |
Fey, PD; Olson, ME; Rupp, ME; Slater, SR | 1 |
Busscher, HJ; Engelsman, AF; Francis, KP; Nejadnik, MR; Ploeg, RJ; Saldarriaga-Fernandez, IC; van Dam, GM; van der Mei, HC | 1 |
Amador, G; Asseray, N; Caillon, J; Jacqueline, C; Le Mabecque, V; Lefebvre, M; Miegeville, A; Potel, G | 1 |
Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Murillo, O; Tubau, F; Verdaguer, R | 2 |
Dhabuwala, C; Sheth, S; Zamzow, B | 1 |
Azeredo, J; Cerca, N; Gomes, F; Leite, B; Oliveira, R; Teixeira, P | 1 |
Juthani, V; Lisman, RD; Rizk, SS; Zoumalan, CI | 1 |
Elkhatib, WF; Noreddin, AM; Salem, AH | 1 |
Jiménez-Mejías, ME; Márquez-Rivas, J; Neth, O; Rivero-Garvía, M; Rueda-Torres, AB | 1 |
Euba, G; Karau, MJ; Mandrekar, JN; Patel, R; Rouse, MS; Schmidt, SM; Steckelberg, JM; Vergidis, P | 1 |
Daubner, B; Pichler, WJ; Wendland, T | 1 |
Caro, E; García, A; Piñar, D; Reus, SJ | 1 |
Alexiou, K; Matschke, K; Reichenspurner, H; Tugtekin, SM; Wilbring, M | 1 |
Cui, L; Hiramatsu, K; Hishinuma, T; Kapi, M; Katayama, Y; Matsuo, M | 1 |
Feng, CH; Higginbottom, PA; Kahn, B; Stevenson, DD | 1 |
Pacheco, SM; Patel, JA; Postelnick, M; Sutton, S | 1 |
Fondelli, S; Iacopi, E; Leonildi, A; Menichetti, F; Piaggesi, A; Rizzo, L; Tagliaferri, E; Tascini, C; Tedeschi, A | 1 |
Crémieux, AC; Dinh, A; Massias, L; Muller-Serieys, C; Saleh-Mghir, A | 1 |
Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
Baig, W; Lowe, E; Patel, PA; Sandoe, J | 1 |
Blanchemain, N; Haulon, S; Hildebrand, HF; Jean-Baptiste, E; Martel, B; Neut, C | 1 |
Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
Breda, R; Janvier, F; Macnab, C; Rigal, S | 1 |
Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA | 1 |
Becker, K; Denis, O; Garcia, LG; Kahl, BC; Lemaire, S; Proctor, RA; Tulkens, PM; Van Bambeke, F | 1 |
Cerca, N; Gomes, F; Oliveira, R; Pereira, S; Teixeira, P | 1 |
Hawari, M; Langley, S; Saad, R; Yousri, T | 1 |
Alkhalil, M; Tate, S | 1 |
Del Prado, G; Doadrio, JC; Esteban, J; Gómez-Barrena, E; Manzano, M; Molina-Manso, D; Ortiz-Pérez, A; Vallet-Regí, M | 1 |
Giebaly, DE; Horriat, S; Mangaleshkar, S; Sinha, A | 1 |
Aslantas, Ö; Demir, C; Erdem, Z; Türkyilmaz, S; Yilmaz, MA | 1 |
Fujitani, S; Ishii, O; Matsuda, T; Nemoto, T; Torikai, K; Yamasaki, Y | 1 |
Goldberg, J; Hacking, SA; Rottman, M | 1 |
Blaskiewicz, DJ; Hall, WA; Li, YM | 1 |
Figueras-Aloy, J; León-Lozano, M; Rodriguez-Guerineau, L; Rodríguez-Miguélez, JM; Salvia-Roigés, MD | 1 |
Castier, MB; Cavalcante, FS; Chamon, RC; Damasco, PV; Ferreira, DC; Marques, EA; Marques, VD; Pastura, MP; Potsch, MV; Rioja, SS; Santos, KR | 1 |
Bowler, IC; Collier, J; Colston, JM; Scarborough, M | 1 |
Gil-Sánchez, S; Lloreda-García, JM; Martinez-Ferrandez, C; Susmozas-Sánchez, J | 1 |
Baj, A; Beltramini, GA; Giannì, AB; Laganà, FC | 1 |
Blackburn, RM; Hill, R; Hope, R; Hopkins, S; Johnson, AP; Kearns, A; Livermore, DM; Sheridan, E; Verlander, NQ | 1 |
Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
Cattoir, V; Dargère, S; Daurel, C; Fines-Guyon, M; Margat, E; Michon, J; Verdon, R | 1 |
Berghaus, LJ; Giguère, S; Guldbech, K | 1 |
Bernthal, NM; Francis, KP; Miller, LS; Niska, JA; Ramos, RI; Shahbazian, JH | 1 |
Cheng, J; Hu, LF; Li, JB; Liu, LG; Ye, Y; Zhu, YL | 1 |
King, AM; Medina, R; Spanogiannopoulos, P; Thaker, MN; Waglechner, N; Wang, W; Wright, GD | 1 |
Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
Garrett, TR; Gosmanova, EO; Wall, BM | 1 |
Abdelhédi Gargouri, L; Ben Abdallah Chabchoub, R; Ben Halima, N; Ben Salah, M; Boukédi, A; Kmiha, S; Maalej, B; Mahfoudh, A; Trabelsi, L; Turki, F | 1 |
Dacombe, PJ; Evans, J; Gosling, OB; Heal, J | 1 |
Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
Bernthal, NM; Billi, F; Francis, KP; Loftin, AH; Miller, LS; Niska, JA; Otto, M; Ramos, RI; Shahbazian, JH; Stavrakis, AI; Uslan, DZ | 1 |
Coelho, FL; de Matos, PD; Dos Santos, KR; Ferreira, DC; Freitas, AI; Iorio, NL; Pereira, MO; Sedaca, S; Sousa, C; Toledo, VC | 1 |
Fröding, I; Håkanson, A; Ottosson, C | 1 |
Arthur, RA; Bottino, MC; Negrini, TC; Waeiss, RA | 1 |
Boyle, MP; Callahan, KA; Dasenbrook, EC; Jennings, MT; Weaver, D | 1 |
Cabellos, C; Force, E; Garrigós, C; Pachón-Ibañez, ME; Taberner, F | 1 |
Fukushima, S; Matsumoto, T; Mizuno, Y; Nakamura, I; Okamura, S; Sato, A; Tsukimori, A; Yamaguchi, T | 1 |
Cochrane, SA; Vederas, JC | 1 |
Ampofo, K; Chin, MJ; Dasenbrook, E; Epps, KL; Marshall, BC; Montague, M; Olson, J; Young, DC; Zobell, JT | 1 |
Mandrekar, JN; Patel, R; Schmidt-Malan, SM; Steckelberg, JM; Vergidis, P | 1 |
Baatsen, P; Claessens, J; Merckx, R; Roriz, M; Van Eldere, J; Van Mellaert, L | 1 |
Chen, SJ; Chou, YL; Hsieh, KH; Lo, WT; Wang, CC | 1 |
Al-Sohaibani, S; Kavitha, K; Murugan, K | 1 |
Dahners, L; Del Gaizo, DJ; Ledbetter, E; Liu, A; Medda, S; van der Horst, AS; Weinhold, P | 1 |
Barber, KE; Boles, BR; Ireland, CE; Rose, WE; Rybak, MJ; Smith, JR | 1 |
Cushman, M; Hammac, GK; Mayhoub, AS; Mohammad, H; Monteleone, D; Reddy, PV; Seleem, MN | 1 |
Bæk, KT; Cameron, DR; Frees, D; Mellergaard, M; Mogenssen, RG; Peleg, AY; Petersen, A; Skov, S; Thomsen, LE; Thøgersen, L | 1 |
Carretero-Ledesma, M; García-Quintanilla, M; Martín-Peña, R; McConnell, MJ; Moreno-Martínez, P; Pachón, J | 1 |
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Chaparro, J; Davis, C; Murphy, E; Pong, A; Viani, RM | 1 |
Chen, S; Shen, Q; Wang, H; Wu, Q | 1 |
Cochrane, SA; He, S; Li, X; Vederas, JC; Wu, M; Yu, M | 1 |
Boudjemaa, R; Boutoille, D; Breteche, A; Caillon, J; Fontaine-Aupart, MP; Jacqueline, C; Le Mabecque, V; Michelet, C; Potel, G; Revest, M; Steenkeste, K; Tattevin, P | 1 |
Busscher, HJ; Kluin, OS; Neut, D; van der Mei, HC | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Avgerinos, ED; Baril, DT; Chaer, RA; Genovese, EA; Makaroun, MS | 1 |
Lora-Tamayo, J; Murillo, O | 1 |
Dagnæs-Hansen, F; Fuursted, K; Jørgensen, NP; Meyer, RL; Petersen, E; Skovdal, SM | 1 |
Gnanasambandam, S; Kanjani, A; Nambi, PS; Prabhudesai, S; Ramachandran, B | 1 |
Dimitriou, G; Gkentzi, D; Kolyva, S; Marangos, M; Spiliopoulou, I | 1 |
Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
Gauger, GE; Larson, PS; Ramos, AD; Rolston, JD | 1 |
Jang, S; Jung, Y; Kang, CH; Shin, Y; So, JS | 1 |
Greenwood-Quaintance, KE; Mandrekar, J; Park, KH; Patel, R | 1 |
Bae, S; Choi, SH; Chong, YP; Kim, HS; Kim, MC; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Park, SJ; Sung, H; Woo, JH | 1 |
Fink, B; Frommelt, L; Oremek, D; Schuster, P; Schwenninger, C | 1 |
García-Alvarez, R; Izquierdo-Barba, I; Vallet-Regí, M | 1 |
Brinkman, CL; Mandrekar, JN; Patel, R; Schmidt-Malan, SM | 1 |
Hyeong Gi, J; Sang Un, L; Sung Chul, K | 1 |
Aguilar-Colomer, A; Doadrio, JC; Esteban, J; Manzano, M; Pérez-Jorge, C; Vallet-Regí, M | 1 |
Hellebrekers, P; Hietbrink, F; Hoekstra, M; Leenen, LP | 1 |
Baud, D; Greub, G; Vouga, M | 1 |
Abd El Fadeal, NM; Hashem, AA; Shehata, AS | 1 |
Becker, K; Bisdas, T; Herten, M; Idelevich, EA; Osada, N; Scherzinger, AS; Sielker, S; Torsello, GB | 1 |
Boudjemaa, R; Briandet, R; Fontaine-Aupart, MP; Steenkeste, K | 1 |
Cipolla, A; Falcone, M; Mastroianni, CM; Oliva, A; Venditti, M; Vullo, V | 1 |
Hsieh, TC; Hsueh, PR; Jean, SS; Ning, YZ | 1 |
Akers, KS; Shiels, SM; Tennent, DJ; Wenke, JC | 1 |
DeJesus, MA; Ehrt, S; Engelhart, CA; Healy, C; Ioerger, TR; Lin, K; Park, SW; Rücker, N; Schnappinger, D; Wang, R; Wright, MG; Xu, W | 1 |
Boldrin, F; Espinosa, DM; Hernandez-Pando, R; Manganelli, R; Palù, G; Payan, JB; Pisu, D; Provvedi, R | 1 |
Domalaon, R; Lyu, Y; Schweizer, F; Yang, X; Zhanel, GG | 1 |
Guzek, A; Rybicki, Z; Suwalski, G; Tomaszewski, D | 1 |
Bogdan, C; Kiefer, A; Melichar, VO | 1 |
Longhurst, WD; Sheele, JM | 1 |
de Alarcón González, A; Domínguez, F; Fariñas, MC; Fernández-Cruz, A; Gálvez-Acebal, J; Gutiérrez-Cuadra, M; HidalgoTenorio, C; Miró, JM; Montejo, JM; Muñoz Serrano, A; Muñoz, P; Ramos-Martínez, A; Ruiz-Morales, J; Sousa-Regueiro, D; Valerio, M | 1 |
Shiels, SM; Tennent, DJ; Wenke, JC | 1 |
Beukes, G; Chang, J; Chengalroyen, M; Ealand, C; Kana, B; Kim, SJ; Machowski, E; Mapela, L; Mashigo, L; Rimal, B | 1 |
Kalyanaraman, M; Morparia, K; Peshkovsky, C | 1 |
Lofgren, AL; Shiels, SM; Tennent, DJ; Wenke, JC | 1 |
Khurana, S; Malhotra, R; Mathur, P | 1 |
Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S | 1 |
Ashcraft, M; Liu, Z; Purro, M; Qiao, J; Xiong, MP | 1 |
Nielsen, SY; Nørskov-Lauritsen, N | 1 |
Bae, IG; Cho, OH; Choi, SH; Chong, YP; Kang, KC; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, MS; Lee, SO; Lee, YM; Moon, C; Park, KH; Park, SY; Ryu, BH; Woo, JH | 1 |
De Angelis, M; Garzoli, S; Marzuillo, C; Mastroianni, CM; Oliva, A; Ragno, R; Vullo, V | 1 |
Goffin, E; Jacques, N; Lancellotti, P; Musumeci, L; Oury, C; Pirotte, B; Servais, L | 1 |
Chang, TY; Chen, HY; Cheng, YH; Chou, YC; Sun, JR | 1 |
Karahan, ZC; Ozmen Capin, BB; Tekeli, A | 1 |
Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
Balaban, NQ; Bar-Meir, M; Gefen, O; Liu, J; Ronin, I | 1 |
Almuwallad, OK; Barnawi, AI; Kassarah, KA; Kordy, FN | 1 |
Arif, S; Bishawi, M; Maskarinec, SA; Milano, C; Miller, RA; Mourad, A | 1 |
Borgen, P; Bragnes, B; Figved, W; Grøgaard, B; Karlsen, ØE; Rydinge, J; Sandberg, L; Snorrason, F; Wangen, H; Westberg, M; Witsøe, E | 1 |
Abdel, MP; Albano, M; Berry, DJ; Karau, MJ; Mandrekar, JN; Oravec, CP; Osmon, DR; Patel, R; Rivera, CG; Schmidt-Malan, SM | 1 |
He, C; Tian, R; Wang, R; Zhang, H | 1 |
Huang, M; Johnson, TM; Kiser, TH; Miller, MA; Molina, KC; Mueller, SW | 1 |
Amanatullah, DF; Bollyky, PL; Lowenberg, DW; Manasherob, R; Mooney, JA | 1 |
Brodt, S; Hartung, A; Jacob, B; Makarewicz, O; Matziolis, G; Roehner, E | 1 |
Alikhani, MY; Arciola, CR; Bagheri, KP; Mirzaei, R; Sedighi, I; Yousefimashouf, R | 1 |
Croughs, PD; Lemmens-den Toom, NA; Sultan, AR; Tavakol, M; van Wamel, WJB; Verbon, A; Verkaik, NJ | 1 |
Collier, CD; Greenfield, EM; Higashihira, S; Kittaka, M; Natoli, RM; Simpson, SJ | 1 |
Aiken, S; Boulton, Z; Brown, L; Delury, C; Fletcher, J; Knight, B; Michell, S; Porter, R; Romanczuk, L | 1 |
Alder, KD; Back, J; Cahill, SV; Dussik, CM; Kwon, HK; Lee, FY; Yu, KE | 1 |
Allen, L; Bartash, R; Cowman, K; Fauvel, D; Guo, Y; Minamoto, GY; Nnani, DU; Patel, S; Vukelic, S | 1 |
Pintarić, S; Štritof, Z; Tumpa, A | 1 |
Benavent, E; El Haj, C; Gomez-Junyent, J; Murillo, O; Rigo-Bonnin, R; Rosselló, I; Sierra, Y; Soldevila, L; Torrejón, B | 1 |
Dong, X; Zhou, P; Zhu, G | 1 |
Bhando, T; Borrillo, L; Brown, ED; Coombes, BK; Farha, MA; Fragis, M; Jardine, E; Johnson, JW; Klobucar, K; MacKinnon, MR; Magolan, J; Nkonge, B; Tsai, CN | 1 |
Habib, A; Qadir, A | 1 |
Bae, S; Choi, SH; Chong, YP; Jung, J; Kim, ES; Kim, MJ; Kim, SH; Kim, YS; Lee, SO; Lee, YW | 1 |
Fujikawa, T; Hasegawa, D; Kasai, M; Kosaka, Y; Mizuno, S; Uemura, S | 1 |
Antoci, V; Bleick, CR; Daffinee, KE; Garcia, D; LaPlante, KL; O'Neill, ET; Williams, G | 1 |
Bleick, C; Daffinee, KE; LaPlante, KL; Piehl, EC | 1 |
Erikstrup, LT; Jensen, LK; Jensen-Fangel, S; Johansen, MI; Jørgensen, NP; Larsen, OH; Meyer, RL; Minero, GAS; Rahbek, SJ; Seefeldt, AM; Østergaard, L | 1 |
Chen, H; Liu, S; Tang, M; Xu, C; Yao, Z; Zhang, X; Zhao, D; Zhou, C; Zhou, T | 1 |
39 review(s) available for vancomycin and rifampin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Glenthmycins A-M: Macrocyclic Spirotetronate Polyketide Antibacterials from the Australian Pasture Plant-Derived
Topics: Amino Sugars; Anthrax; Anti-Bacterial Agents; Australia; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Polyketides; Streptomyces | 2022 |
Antimicrobial therapy in infants and children. Part I. Review of antimicrobial agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Clindamycin; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Infant; Kidney Diseases; Lincomycin; Nalidixic Acid; Nitrofurans; Oxolinic Acid; Penicillin Resistance; Penicillins; Polymyxins; Rifampin; Sulfamethoxazole; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1978 |
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence.
Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Lincomycin; Mycoses; Nalidixic Acid; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Staphylococcal Infections; Sulfamethoxazole; Tetracyclines; Trimethoprim; Urinary Tract Infections; Vancomycin | 1979 |
Severe Rhodococcus equi pneumonia: case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Drug Therapy, Combination; Erythromycin; Humans; Immunocompromised Host; Male; Pneumonia; Rhodococcus equi; Rifampin; Vancomycin | 1991 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
Antibacterial therapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clindamycin; Drug Combinations; Erythromycin; Humans; Methicillin; Metronidazole; Nalidixic Acid; Penicillin Resistance; Penicillins; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Antibiotic monitoring in body fluids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Biological Assay; Body Fluids; Cephalosporins; Chloramphenicol; Chromatography, Gas; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Humans; Immunoassay; Monitoring, Physiologic; Penicillins; Rifampin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thiamphenicol; Vancomycin | 1985 |
Antimicrobial therapy in infants and children: update 1976-1985. Part II.
Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Erythromycin; Humans; Infant; Nitrofurantoin; Penicillins; Rifampin; Sulfamethoxazole; Sulfisoxazole; Trimethoprim; Vancomycin | 1985 |
Shunt infections: prevention and treatment.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Injections, Intravenous; Injections, Intraventricular; Klebsiella Infections; Leukocytes; Meningitis; Premedication; Pseudomonas Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
[Antibiotic therapy: general principles, principle antibiotics, their indications and side effects].
Topics: Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Gentamicins; Humans; Infections; Lincomycin; Penicillins; Polymyxins; Rifampin; Tetracycline; Vancomycin | 1971 |
[Antibiotics. Clinical use and adverse effects].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Erythromycin; Humans; Penicillin Resistance; Penicillins; Rifampin; Ristocetin; Tetracycline; Vancomycin | 1972 |
[Actual problems in clinical chemotherapy].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cephalosporins; Endocarditis, Bacterial; Enteritis; Gentamicins; Humans; Infections; Lincomycin; Meningitis; Penicillins; Rifampin; Sepsis; Staphylococcal Infections; Streptococcal Infections; Sulfonamides; Urinary Tract Infections; Vancomycin | 1967 |
Clinical implications of the mechanism of action of antimicrobial agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacitracin; Cell Membrane; Cell Wall; Cephalosporins; Chloramphenicol; Cycloserine; Drug Synergism; Erythromycin; Humans; Nalidixic Acid; Novobiocin; Nucleic Acids; Penicillin Resistance; Penicillins; Protein Biosynthesis; Rifampin; Ristocetin; Sulfonamides; Tetracycline; Vancomycin | 1970 |
Antimicrobial agents and the central nervous system.
Topics: Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Cephamycins; Chloramphenicol; Erythromycin; Humans; Infections; Lincomycin; Meningitis; Metronidazole; Penicillins; Polymyxins; Rifampin; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1980 |
Vancomycin therapy of severe staphylococcal infections.
Topics: Aminoglycosides; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Vancomycin | 1984 |
Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Topics: Australia; beta-Lactamases; Cephalosporins; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Vancomycin, trimethoprim-sulfamethoxazole, and rifampin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antibiotics, Antitubercular; Drug Resistance, Microbial; Humans; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1995 |
Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.
Topics: Aged; Autoimmune Diseases; Basement Membrane; Captopril; Drug Eruptions; Female; Humans; Immunoglobulin A; Male; Phenytoin; Rifampin; Skin; Skin Diseases, Vesiculobullous; Somatostatin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1994 |
Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
Topics: Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1994 |
Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Vancomycin | 1995 |
Retroperitoneal pseudomeningocele complicated by meningitis following a lumbar burst fracture. A case report.
Topics: Adolescent; Drainage; Drug Therapy, Combination; Humans; Lumbar Vertebrae; Male; Meningitis; Meningocele; Retroperitoneal Space; Rifampin; Spinal Fractures; Staphylococcal Infections; Staphylococcus epidermidis; Tomography, X-Ray Computed; Vancomycin | 1996 |
[Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Pneumococcal; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chloramphenicol; Clindamycin; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Lactams; Male; Meningitis, Bacterial; Naphthyridines; Penicillin Resistance; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1997 |
In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options.
Topics: Drug Synergism; Drug Therapy, Combination; Female; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1998 |
Staphylococcus capitis endocarditis: two cases and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Aortic Valve; Endocarditis, Bacterial; Heart Valve Diseases; Humans; Male; Middle Aged; Rifampin; Staphylococcal Infections; Vancomycin | 1999 |
Emergence of drug resistance. Impact on bacterial meningitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Humans; Meningitis, Bacterial; Neisseria meningitidis; Penicillins; Rifampin; Streptococcus pneumoniae; Vancomycin | 1999 |
[Penile prostheses and infection].
Topics: Bacterial Infections; Diabetes Complications; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Penile Prosthesis; Penis; Postoperative Complications; Rifampin; Risk Factors; Vancomycin | 2002 |
Fulminant Listeria monocytogenes meningitis complicated with acute hydrocephalus in healthy children beyond the newborn period.
Topics: Acute Disease; Amikacin; Cefotaxime; Child; Child, Preschool; Combined Modality Therapy; Costa Rica; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Emergencies; Fatal Outcome; Female; Humans; Hydrocephalus; Male; Meningitis, Listeria; Meropenem; Rifampin; Thienamycins; Tomography, X-Ray Computed; Vancomycin; Ventriculostomy | 2004 |
Severe staphylococcal knee arthritis responding favourably to linezolid, after glycopeptide-rifampicin failure: a case report and literature review.
Topics: Acetamides; Anti-Bacterial Agents; Arthritis, Infectious; Drug Therapy, Combination; HIV Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin; Staphylococcal Infections; Teicoplanin; Vancomycin | 2005 |
Community associated MRSA: an alert to paediatricians.
Topics: Anti-Bacterial Agents; Child; Community-Acquired Infections; Drug Therapy, Combination; Genotype; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Soccer; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Randomized Controlled Trials as Topic; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
Progress in Understanding the Genetic Information and Biosynthetic Pathways behind Amycolatopsis Antibiotics, with Implications for the Continued Discovery of Novel Drugs.
Topics: Actinomycetales; Anti-Bacterial Agents; Biosynthetic Pathways; Drug Discovery; Rifampin; Vancomycin | 2016 |
Treatment Options for Persistent Coagulase Negative Staphylococcal Bacteremia in Neonates.
Topics: Anti-Infective Agents; Daptomycin; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Linezolid; Retrospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Spinal Subdural Abscess Following Laminectomy for Symptomatic Stenosis: A Report of 2 Cases and Review of the Literature.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Body Mass Index; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Epidural Abscess; Humans; Laminectomy; Lumbar Vertebrae; Male; Middle Aged; Rifampin; Risk Factors; Schizophrenia; Spinal Stenosis; Staphylococcal Infections; Suction; Treatment Outcome; Vancomycin | 2016 |
Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Immunocompromised Host; Infant, Low Birth Weight; Infant, Newborn; Linezolid; Meningitis, Bacterial; Rifampin; Treatment Outcome; Vancomycin | 2017 |
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
14 trial(s) available for vancomycin and rifampin
Article | Year |
---|---|
Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Adult; Bacteremia; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fever; Gentamicins; Humans; Male; Methicillin Resistance; Middle Aged; Prospective Studies; Rifampin; Staphylococcal Infections; Statistics as Topic; Time Factors; Vancomycin | 1991 |
Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.
Topics: Administration, Intranasal; Anti-Bacterial Agents; Bacitracin; Bacteriophage Typing; Carrier State; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Evaluation, Preclinical; Humans; Injections, Intravenous; Nose; Prospective Studies; Random Allocation; Renal Dialysis; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1986 |
Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.
Topics: Blood Bactericidal Activity; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Random Allocation; Rifampin; Sepsis; Staphylococcal Infections; Vancomycin | 1985 |
Continuous ambulatory peritoneal dialysis catheter infections: diagnosis and management.
Topics: Bacterial Infections; Catheterization; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1994 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Injections, Intravenous; Middle Aged; Neutropenia; Rifampin; Stem Cell Transplantation; Tobramycin; Vancomycin | 1994 |
Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.
Topics: Acute Disease; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Child, Preschool; Dexamethasone; Humans; Infant; Meningitis, Pneumococcal; Rifampin; Serum Bactericidal Test; Streptococcus pneumoniae; Vancomycin | 1995 |
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Infusions, Intravenous; Length of Stay; Male; Oxacillin; Penicillins; Prospective Studies; Rifampin; Staphylococcal Infections; Substance Abuse, Intravenous; Treatment Outcome; Vancomycin | 1996 |
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Orthopedic Fixation Devices; Penicillins; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1998 |
Two-stage treatment of chronic staphylococcal orthopaedic implant-related infections using vancomycin impregnated PMMA spacer and rifampin containing antibiotic protocol.
Topics: Adult; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Chronic Disease; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 1999 |
Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns.
Topics: Adolescent; Adult; Bacteremia; Burn Units; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Kuwait; Male; Methicillin Resistance; Middle Aged; Prognosis; Prospective Studies; Rifampin; Staphylococcal Infections; Survival Rate; Treatment Outcome; Vancomycin | 1999 |
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
Topics: Administration, Oral; Adult; Aged; Bacteremia; Catheters, Indwelling; Drug Therapy, Combination; Female; Fleroxacin; Floxacillin; Humans; Male; Methicillin Resistance; Middle Aged; Prospective Studies; Rifampin; Safety; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2004 |
Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; Hospital Mortality; Humans; Intensive Care Units; Korea; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Probability; Prospective Studies; Rifampin; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vancomycin | 2010 |
Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Cystic Fibrosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Nebulizers and Vaporizers; Remission Induction; Research Design; Rifampin; Staphylococcal Infections; Vancomycin | 2014 |
Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cloxacillin; Debridement; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2020 |
513 other study(ies) available for vancomycin and rifampin
Article | Year |
---|---|
Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.
Topics: Anti-Bacterial Agents; Escherichia coli; Glycosylation; Photochemotherapy; Porphyrins; Staphylococcus aureus | 1998 |
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Asteraceae; Candida albicans; Disease Models, Animal; DNA; Drug Resistance, Microbial; Enterococcus faecium; Escherichia coli; Female; Magnetic Resonance Spectroscopy; Mexico; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Phenols; Plant Roots; Plants, Medicinal; Protein Biosynthesis; Proteins; RNA; Spectrophotometry, Ultraviolet; Staphylococcus aureus; Vancomycin | 2001 |
Antibacterial diterpenes from Calceolaria pinifolia.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacillus subtilis; Diterpenes; Erythrocytes; Escherichia coli; Female; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Plants, Medicinal; Scrophulariaceae; Staphylococcus aureus | 2003 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Topics: Acetamides; Aminoglycosides; Biofilms; Catheters, Indwelling; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Fluoroquinolones; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Morganella morganii; Oxazolidinones; Penicillins; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Catheterization; Vancomycin; Vancomycin Resistance | 2007 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; DNA, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillin-Binding Proteins; Penicillins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus; Tetracycline | 2007 |
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
Topics: Bacterial Proteins; Cell Lineage; DNA Transposable Elements; Genetic Variation; Poland; Streptococcus pneumoniae; Tetracycline; Tetracycline Resistance | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Monocytes; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 2007 |
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Topics: Animals; Arabinofuranosyluracil; Cell Line; Cell Survival; Chlorocebus aethiops; Drug Resistance, Bacterial; Floxuridine; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Rifampin; Structure-Activity Relationship | 2007 |
Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens.
Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Benzophenones; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Mycobacterium; Naphthols; Staphylococcus aureus; Staphylococcus epidermidis | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Humans; Michigan; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
Topics: Anti-Bacterial Agents; Cells, Cultured; Daptomycin; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcus aureus | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.
Topics: Anti-Bacterial Agents; Area Under Curve; Colony Count, Microbial; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Vancomycin | 2008 |
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Gene Expression Regulation, Bacterial; Lac Operon; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Recombinant Fusion Proteins; Staphylococcus aureus | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
Characterization of TolC efflux pump proteins from Pasteurella multocida.
Topics: Amino Acid Sequence; Animals; Bacterial Outer Membrane Proteins; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Membrane Transport Proteins; Mutation; Pasteurella multocida; Phylogeny | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
Topics: Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, Teaching; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections | 2009 |
Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Glycopeptides; Kinetics; Lipoglycopeptides; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Plankton; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Folic Acid Antagonists; Microbial Sensitivity Tests; Phthalazines; Staphylococcus aureus; Staphylococcus epidermidis; Tetrahydrofolate Dehydrogenase | 2009 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Topics: Aminoglycosides; Gentamicins; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Vancomycin | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Blotting, Northern; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Imipenem; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cyclic GMP-Dependent Protein Kinases; Drug Resistance, Microbial; Mycobacterium; Mycobacterium tuberculosis; Phagosomes; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin | 2009 |
Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Fibroblasts; Humans; Male; Mice; Pyrrolidinones; Staphylococcal Skin Infections; Tenuazonic Acid | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
Topics: Animals; Anti-Bacterial Agents; Bacillus anthracis; Cell Death; Cell Line; Gram-Negative Bacteria; Gram-Positive Bacteria; Macrophages; Mice; Staphylococcus aureus; Yersinia pestis | 2009 |
Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Foreign-Body Reaction; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats; Rats, Wistar | 2009 |
Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents.
Topics: Amides; Animals; Anti-Bacterial Agents; Benzophenones; Cell Membrane; Cell Wall; CHO Cells; Cricetinae; Cricetulus; DNA, Bacterial; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Protein Biosynthesis; RNA, Bacterial; Staphylococcus aureus; Structure-Activity Relationship | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Norselic acids A-E, highly oxidized anti-infective steroids that deter mesograzer predation, from the Antarctic sponge Crella sp.
Topics: Animals; Antarctic Regions; Anti-Infective Agents; Candida albicans; Enterococcus faecium; Leishmania; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Porifera; Staphylococcal Infections; Steroids; Vancomycin Resistance | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
In vitro activity of fidaxomicin (OPT-80) tested against contemporary clinical isolates of Staphylococcus spp. and Enterococcus spp.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Fidaxomicin; Humans; In Vitro Techniques; Staphylococcus | 2010 |
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
Topics: Animals; Daptomycin; Endocarditis; Glycopeptides; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2010 |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Clarithromycin; Daptomycin; Fluoroquinolones; Microscopy, Electron, Scanning; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Vancomycin | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromatography, Liquid; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Glycopeptides; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Polymerase Chain Reaction | 2010 |
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Multiple, Bacterial; Mutation; Polymorphism, Single Nucleotide; Staphylococcus aureus; Vancomycin | 2010 |
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
Topics: Anti-Bacterial Agents; Indonesia; Methicillin; Methicillin Resistance; Phylogeny; Polymerase Chain Reaction; Staphylococcus | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
One-pot syntheses of pseudopteroxazoles from pseudopterosins: a rapid route to non-natural congeners with improved antimicrobial activity.
Topics: Anti-Bacterial Agents; Diterpenes; Enterococcus faecium; Glycosides; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazoles; Staphylococcus aureus; Stereoisomerism; Vancomycin | 2011 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase.
Topics: Anti-Bacterial Agents; High-Throughput Screening Assays; Inorganic Pyrophosphatase; Mycobacterium tuberculosis; Staphylococcus aureus; Structure-Activity Relationship; Triazines | 2014 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Structure-activity relationship for the oxadiazole class of antibiotics.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Staphylococcus aureus; Structure-Activity Relationship | 2015 |
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Enzyme Assays; Escherichia coli; Gene Expression; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phthalic Anhydrides; Spermidine; Succinic Anhydrides | 2015 |
Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Computational Biology; Dose-Response Relationship, Drug; Fungi; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Rifamycins; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cell Line; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium Infections; Nucleosides; Pyrimidines; Structure-Activity Relationship | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Small molecule mimics of DFTamP1, a database designed anti-Staphylococcal peptide.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Design; Molecular Structure; Peptides; Small Molecule Libraries; Structure-Activity Relationship | 2017 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Species Specificity; Structure-Activity Relationship; Tetrazoles | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Enterococcus faecium; Indonesia; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Porifera; Staphylococcus aureus | 2017 |
Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cell Line; Chemical Phenomena; Cricetinae; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxadiazoles; Rats; Solubility; Structure-Activity Relationship; Thiazoles | 2018 |
Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caco-2 Cells; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats, Sprague-Dawley; Staphylococcal Infections; Thiazoles | 2018 |
An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
Topics: Anti-Bacterial Agents; Biofilms; Cyclization; Halogenation; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenazines | 2018 |
Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens.
Topics: Animals; Anti-Bacterial Agents; Caco-2 Cells; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Molecular Structure; Rats; Rats, Sprague-Dawley; Staphylococcus; Structure-Activity Relationship; Thiazoles | 2018 |
Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Staphylococcal Infections; Structure-Activity Relationship; Triazoles | 2018 |
Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Isoxazoles; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Oxazolidinones | 2018 |
Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.
Topics: Amides; Anti-Bacterial Agents; Biofilms; Chaperonin 10; Chaperonin 60; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |
Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2019 |
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship | 2019 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity.
Topics: Animals; Anti-Bacterial Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line; Chromatography, Liquid; Enzyme Inhibitors; Lipids; Macrophages; Mass Spectrometry; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Pyrophosphatases; Structure-Activity Relationship; Thiazoles | 2019 |
Design, synthesis and biological evaluation of antimicrobial diarylimine and -amine compounds targeting the interaction between the bacterial NusB and NusE proteins.
Topics: Aniline Compounds; Anti-Bacterial Agents; Bacterial Proteins; Benzylamines; Caco-2 Cells; Drug Design; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Hemolysis; Humans; Keratinocytes; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Schiff Bases; Structure-Activity Relationship; Transcription Factors | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Fatty Acids; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Molecular Structure; RAW 264.7 Cells; Structure-Activity Relationship | 2019 |
Design, synthesis and biological evaluation of novel hybrids of N-aryl pyrrothine-base α-pyrone as bacterial RNA polymerase inhibitors.
Topics: Anti-Bacterial Agents; Binding Sites; Candida albicans; Cell Survival; DNA-Directed RNA Polymerases; Drug Design; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Pyrones; Structure-Activity Relationship | 2020 |
Discovery of Antibacterials That Inhibit Bacterial RNA Polymerase Interactions with Sigma Factors.
Topics: Amino Acid Sequence; Aniline Compounds; Anti-Bacterial Agents; Bacterial Proteins; Benzophenones; Cell Line, Tumor; DNA-Directed RNA Polymerases; Humans; Microbial Sensitivity Tests; Molecular Structure; Protein Multimerization; Sequence Alignment; Sigma Factor; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfides | 2020 |
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Staphylococcal Infections; Structure-Activity Relationship; Thiazoles | 2020 |
Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction.
Topics: Animals; Bacteria; Bacterial Proteins; Benzoates; Benzophenones; Benzyl Compounds; DNA-Directed RNA Polymerases; Microbial Sensitivity Tests; Microsomes, Liver; Protein Binding; Rats; Sigma Factor | 2020 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Discovery of novel N
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytidine; Drug Discovery; Fungi; Humans; Microbial Sensitivity Tests | 2021 |
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Liver; Microbial Sensitivity Tests; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzothiazoles; Cytoskeletal Proteins; Humans; Indoles; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Voatriafricanines A and B, Trimeric Vobasine-Aspidosperma-Aspidosperma Alkaloids from
Topics: Anti-Bacterial Agents; Cameroon; Indole Alkaloids; Molecular Structure; Phytochemicals; Plant Bark; Voacanga | 2021 |
Antimicrobial and Cytotoxic Angucyclic Quinones from
Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones | 2021 |
Design, synthesis, and antibacterial activity of
Topics: | 2021 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Methicillin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Vancomycin-Resistant Staphylococcus aureus | 2022 |
Spermine-Conjugated Short Proline-Rich Lipopeptides as Broad-Spectrum Intracellular Targeting Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Escherichia coli; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Proline; Spermine; Staphylococcus aureus | 2022 |
Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study.
Topics: Amines; Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
Topics: Blood; Child, Preschool; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Infant; Male; Methicillin; Penicillin Resistance; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1978 |
Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Cefamandole; Cephalothin; Drug Synergism; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcus; Time Factors; Vancomycin | 1979 |
The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.
Topics: Adult; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Rifampin; Staphylococcal Infections; Vancomycin | 1978 |
In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.
Topics: Drug Synergism; Microbial Sensitivity Tests; Nafcillin; Rifampin; Staphylococcus aureus; Vancomycin | 1978 |
Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices.
Topics: Adolescent; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Drug Synergism; Endocarditis, Bacterial; Female; Gentamicins; Heart Valve Prosthesis; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Nafcillin; Postoperative Complications; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1978 |
Factors regulating cell wall thickening and intracellular iodophilic polysaccharide storage in Streptococcus mutans.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Chloramphenicol; Cycloserine; DNA, Bacterial; Penicillin G; Peptidoglycan; Polysaccharides, Bacterial; Rifampin; RNA, Bacterial; Streptococcus; Streptococcus mutans; Vancomycin | 1977 |
Sepsis with a new species of Corynebacterium.
Topics: Adult; Child; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Female; Humans; Male; Rifampin; Vancomycin | 1976 |
Antimicrobial therapy of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Bacteria; Humans; Lincomycin; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Thiamphenicol; Vancomycin | 1975 |
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Penicillins; Rabbits; Rifampin; Staphylococcal Infections; Time Factors; Vancomycin | 1975 |
[Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Topics: Amoxicillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Erythromycin; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Penicillin G; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1992 |
Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
Topics: Animals; Cells, Cultured; Chronic Disease; Drug Interactions; Drug Therapy, Combination; Fleroxacin; Foreign-Body Reaction; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Microbial; Fleroxacin; Foreign Bodies; Gentamicins; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Staphylococcus aureus exit-site and tunnel infection in CAPD.
Topics: Catheters, Indwelling; Debridement; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Povidone-Iodine; Rifampin; Staphylococcal Skin Infections; Vancomycin | 1990 |
In vitro synergy studies with Clostridium difficile.
Topics: Bacitracin; Clostridioides difficile; Drug Combinations; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1991 |
CAPD peritonitis caused by vancomycin-resistant lactobacilli.
Topics: Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Lactobacillus; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rifampin; Vancomycin | 1990 |
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Fleroxacin; Foreign-Body Reaction; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
Impact of postantibiotic effect on bacterial adherence to vascular prostheses.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Blood Vessel Prosthesis; Cefazolin; Cells, Cultured; Microscopy, Electron, Scanning; Polyethylene Terephthalates; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1990 |
[Sensitivity curves of multiply resistant corynebacteria JK and D2].
Topics: Anti-Bacterial Agents; Corynebacterium; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Glycopeptides; In Vitro Techniques; Rifampin; Teicoplanin; Vancomycin | 1990 |
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1990 |
Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Topics: Catheters, Indwelling; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1990 |
[Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Disinfectants; Humans; Lactams; Macrolides; Methicillin Resistance; Postoperative Complications; Quinolones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines; Vancomycin | 1990 |
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin; Osteomyelitis; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Fluoroquinolones; Male; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
A laboratory-confirmed outbreak of rifampicin-methicillin resistant Staphylococcus aureus (RMRSA) in a newborn nursery.
Topics: Bacterial Typing Techniques; Bacteriophage Typing; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Infant, Newborn; Male; Methicillin; Nurseries, Hospital; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Antibiotic activity against Staphylococcus epidermidis biofilms in dialysis fluids.
Topics: Bacterial Adhesion; Culture Media; Dialysis Solutions; Drug Resistance, Microbial; Hydrogen-Ion Concentration; Rifampin; Staphylococcus epidermidis; Vancomycin | 1989 |
Suppression of rifampicin-resistant variants of Staphylococcus aureus.
Topics: Colony Count, Microbial; Drug Resistance, Microbial; Rifampin; Staphylococcus aureus; Vancomycin | 1989 |
The activity of rifampin and analogs against Staphylococcus epidermidis biofilms in a CAPD environment model.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Rifampin; Rifamycins; Staphylococcus epidermidis; Structure-Activity Relationship; Vancomycin | 1989 |
In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
Topics: Anti-Bacterial Agents; Daptomycin; Fusidic Acid; Glycopeptides; Gram-Positive Bacteria; Microbial Sensitivity Tests; Peptides; Rifampin; Teicoplanin; Vancomycin | 1987 |
Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Erythromycin; Humans; Methicillin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Streptomycin; Vancomycin | 1986 |
Activity of teicoplanin in localized experimental infections in rats.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Glycopeptides; Granuloma; Male; Methicillin; Penicillin Resistance; Rats; Rats, Inbred F344; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Teicoplanin; Vancomycin | 1986 |
Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Endocarditis, Bacterial; Female; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1986 |
Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Glycopeptides; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1987 |
Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Topics: Fusidic Acid; Gentamicins; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1988 |
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin | 1987 |
A prolonged infection after valve replacement.
Topics: Aortic Valve; Aortic Valve Stenosis; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Vancomycin | 1986 |
Determination of the effect of antimicrobics in combination against Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefotaxime; Drug Combinations; Drug Synergism; Erythromycin; Gentamicins; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Moxalactam; Penicillin G; Rifampin; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fusidic Acid; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus Phages; Teicoplanin; Vancomycin | 1985 |
Time kill curve analysis of vancomycin and rifampin alone and in combination against nine strains of nutritionally deficient streptococci.
Topics: Drug Synergism; Endocarditis, Bacterial; Humans; Rifampin; Streptococcal Infections; Streptococcus; Time Factors; Vancomycin | 1988 |
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1987 |
Staphylococcus epidermidis endocarditis and mitral valve prolapse.
Topics: Adult; Endocarditis, Bacterial; Floxacillin; Fusidic Acid; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Prolapse; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Antibiotic resistance pattern of Flavobacterium meningosepticum.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Flavobacterium; Humans; Infant, Newborn; Isoelectric Focusing; Rifampin; Tetracycline; Vancomycin | 1986 |
Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
Topics: Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Colitis; Diarrhea; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Vancomycin | 1987 |
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Osteomyelitis; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1987 |
Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
Topics: Drug Combinations; Methicillin; Microbial Sensitivity Tests; Novobiocin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1986 |
Outbreak due to methicillin- and rifampin-resistant Staphylococcus aureus: epidemiology and eradication of the resistant strain from the hospital.
Topics: Carrier State; Cross Infection; Disease Outbreaks; Female; Hospital Bed Capacity, 500 and over; Humans; Intensive Care Units; Male; Methicillin; Middle Aged; Penicillin Resistance; Personnel, Hospital; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginia | 1987 |
Comparison of agar disk diffusion, microdilution broth, and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cephalosporins; Coagulase; Culture Media; Drug Resistance, Microbial; Fusidic Acid; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rifampin; Sodium Chloride; Staphylococcus; Temperature; Vancomycin | 1987 |
Induction of mutants resistant to antibiotics in Brevibacterium flavum.
Topics: Anti-Bacterial Agents; Brevibacterium; Drug Resistance, Microbial; Erythromycin; Hydrogen-Ion Concentration; Methylnitronitrosoguanidine; Mutation; Neomycin; Oleandomycin; Rifampin; Streptomycin; Ultraviolet Rays; Vancomycin | 1986 |
Staphylococcus epidermidis in diabetic urological patient.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Diabetes Complications; Drug Resistance, Microbial; Erectile Dysfunction; Humans; Male; Middle Aged; Penis; Prostheses and Implants; Prosthesis Failure; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Testis; Vancomycin | 1986 |
Staphylococcus epidermidis ventriculitis treated with vancomycin and rifampin.
Topics: Anti-Bacterial Agents; Cerebral Ventricles; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Child; Craniocerebral Trauma; Encephalitis; Female; Humans; Infant; Injections, Intraventricular; Male; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1986 |
Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cell Wall; Methicillin; Microbial Sensitivity Tests; Nafcillin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Vancomycin | 1985 |
Choosing antimicrobials. Factors to consider, available agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Clindamycin; Drug Interactions; Drug Therapy, Combination; Erythromycin; Humans; Kidney Failure, Chronic; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Tissue Distribution; Vancomycin | 1985 |
Methicillin-resistant Staphylococcus aureus: clinical and laboratory features.
Topics: Cross Infection; Disease Outbreaks; Drug Interactions; Hand Disinfection; Humans; Methicillin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 1985 |
Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Amikacin; Animals; Child; Drug Therapy, Combination; Humans; Kanamycin; Kinetics; Meningitis; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1985 |
Prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis and Micrococcus species successfully treated with rifampicin combined with other antibiotics.
Topics: Adult; Aminoglycosides; Drug Combinations; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Methicillin; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1985 |
In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
Topics: Clindamycin; Drug Combinations; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1986 |
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
Topics: Animals; Creatinine; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Kidney; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1985 |
Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Reoperation; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
Pirprofen-induced fulminant hepatitis.
Topics: Aged; Alanine Transaminase; Amikacin; Chemical and Drug Induced Liver Injury; Female; Humans; Middle Aged; Phenylpropionates; Rifampin; Spondylitis, Ankylosing; Staphylococcal Infections; Vancomycin | 1985 |
In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Colistin; Dihydrostreptomycin Sulfate; Drug Synergism; Erythromycin; Flavobacterium; Folic Acid Antagonists; Gentamicins; Kanamycin; Lincomycin; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Novobiocin; Penicillins; Pyrimidines; Rifampin; Sulfamethoxazole; Tetracycline; Vancomycin | 1971 |
Gonogrow, an improved, selective medium for the isolation of Neisseria gonorrhoeae.
Topics: Bacteria; Candida albicans; Clindamycin; Colistin; Culture Media; Drug Storage; Gonorrhea; Humans; Neisseria gonorrhoeae; New York; Nystatin; Rifampin; Vancomycin | 1974 |
In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bacteriological Techniques; Chick Embryo; Chloramphenicol; Culture Techniques; Dimethyl Sulfoxide; Doxycycline; Erythromycin; Gentamicins; Kanamycin; Minocycline; Neomycin; Oxacillin; Penicillin G; Rickettsia Infections; Rickettsia prowazekii; Rifampin; Streptomycin; Tetracycline; Ultrafiltration; Vancomycin | 1974 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
Antibiotic sensitivity of staphylococci isolated in Ulanbator. On the occasion of the 50th anniversary of the Mongolian health services.
Topics: Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Kanamycin; Leucomycins; Lincomycin; Microbial Sensitivity Tests; Mongolia; Neomycin; Oxacillin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1972 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.
Topics: Ampicillin; Animals; Cephaloridine; Clindamycin; Endocarditis, Bacterial; Erythromycin; Female; Male; Penicillin G; Rabbits; Rifampin; Streptococcal Infections; Streptomycin; Tetracycline; Vancomycin | 1973 |
Endocarditis due to anaerobic gram-negative bacilli.
Topics: Bacteria; Bacteroides; Bacteroides Infections; Chloramphenicol; Embolism; Endocarditis, Bacterial; Erythromycin; Humans; Lincomycin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Rifampin; Tetracycline; Vancomycin | 1973 |
Antimicrobial considerations in anaerobic infections.
Topics: Actinomycetales Infections; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium Infections; Erythromycin; Fusobacterium; Humans; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Oxygen; Penicillins; Rifampin; Streptococcal Infections; Tetracycline; Treponemal Infections; Vancomycin; Veillonella | 1974 |
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides; Clindamycin; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Vancomycin | 1972 |
[Sensitivity of staphylococci to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Chlortetracycline; Culture Media; Erythromycin; Kanamycin; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcus; Streptomycin; Vancomycin; Virginiamycin | 1966 |
Staphylococcal CNS infections treated with vancomycin and rifampin.
Topics: Adolescent; Brain Diseases; Cellulitis; Central Nervous System Diseases; Drug Therapy, Combination; Empyema, Subdural; Female; Humans; Infant; Male; Meningitis; Orbital Diseases; Rifampin; Staphylococcal Infections; Vancomycin | 1984 |
In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
Topics: Anti-Bacterial Agents; Bacteria; Drug Interactions; Microbial Sensitivity Tests; Rifampin; Teicoplanin; Vancomycin | 1983 |
Comparative in vitro activities of teichomycin and other antibiotics against JK diphtheroids.
Topics: Anti-Bacterial Agents; Corynebacterium diphtheriae; Microbial Sensitivity Tests; Rifampin; Teicoplanin; Vancomycin | 1983 |
Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Synergism; Enterococcus faecalis; Microbial Sensitivity Tests; Rifampin; Staphylococcus; Staphylococcus aureus; Teicoplanin; Vancomycin | 1984 |
Activity of rifampicin against staphylococci, with special reference to multiresistant strains.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Synergism; Mutation; Novobiocin; Rifampin; Staphylococcus; Teicoplanin; Time Factors; Vancomycin | 1984 |
[A case of primary peritonitis and bilateral pneumonia caused by staphylococcal emboli in drug dependence].
Topics: Adolescent; Female; Heroin Dependence; Humans; Injections, Intravenous; Peritonitis; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Vancomycin | 1984 |
In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
Topics: Anti-Bacterial Agents; Dicloxacillin; Drug Combinations; Drug Synergism; Endocarditis, Bacterial; Fusidic Acid; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Vancomycin | 1984 |
Antimicrobial susceptibility of 200 blood isolates of coagulase-negative staphylococci to 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Gentamicins; Microbial Sensitivity Tests; Nafcillin; Rifampin; Staphylococcus; Vancomycin | 1984 |
Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
Topics: Coagulase; Drug Combinations; Drug Synergism; Gentamicins; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcus; Vancomycin | 1983 |
Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Topics: Drug Synergism; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1984 |
In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci.
Topics: Drug Combinations; Drug Synergism; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1984 |
Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Carrier State; Child; Drug Combinations; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1984 |
Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.
Topics: Aminoglycosides; Bacillus subtilis; Biological Assay; Drug Synergism; Microbiological Techniques; Rifampin; Vancomycin | 1980 |
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Topics: Culture Media; Fusidic Acid; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcus aureus; Vancomycin | 1983 |
Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.
Topics: Animals; Chronic Disease; Drug Therapy, Combination; Female; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1983 |
Methicillin-resistant Staphylococcus aureus.
Topics: Aged; Endocarditis, Bacterial; Humans; Male; Methicillin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Vancomycin | 1983 |
Fatal meningitis with group JK Corynebacterium in a leukopenic patient.
Topics: Adult; Burkitt Lymphoma; Corynebacterium; Humans; Leukopenia; Male; Meningitis; Rifampin; Vancomycin | 1983 |
Enterococcal meningitis: combined vancomycin and rifampin therapy.
Topics: Administration, Oral; Chloramphenicol; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Injections, Spinal; Male; Meningitis; Middle Aged; Penicillins; Rifampin; Streptococcal Infections; Vancomycin | 1980 |
Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Gentamicins; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Vancomycin | 1982 |
Depression of colony formation by human thymus-derived lymphocytes with rifampin and other antimicrobial agents.
Topics: Adult; Antifungal Agents; Chloramphenicol; Clindamycin; Clone Cells; Erythromycin; Humans; Mycobacterium; Rifampin; T-Lymphocytes; Troleandomycin; Vancomycin | 1981 |
Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain.
Topics: Animals; Catalase; Humans; Lethal Dose 50; Male; Methicillin; Mice; Penicillin Resistance; Penicillinase; Phagocytosis; Rifampin; Staphylococcal Protein A; Staphylococcus aureus; Temperature; Vancomycin; Virulence | 1981 |
Antimicrobial susceptibility of Clostridium difficile from different sources.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clostridium; Clostridium Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Rifampin; Vancomycin | 1982 |
Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Treatment of mice infected with methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Male; Methicillin; Mice; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin | 1982 |
Cure of Ommaya reservoir associated Staphylococcus epidermidis ventriculitis with a simple regimen of vancomycin and rifampin without reservoir removal.
Topics: Adult; Brain Diseases; Cerebral Ventricles; Drug Implants; Drug Therapy, Combination; Humans; Lymphoma; Male; Meningeal Neoplasms; Rifampin; Staphylococcal Infections; Vancomycin | 1982 |
Effects of a vancomycin-rifampin combination on enterococci.
Topics: Drug Combinations; Rifampin; Streptococcus; Vancomycin | 1982 |
Staphylococcus aureus infection of dialysis shunt: absence of synergy with vancomycin and rifampin.
Topics: Aged; Arteriovenous Shunt, Surgical; Drug Synergism; Drug Therapy, Combination; Humans; Male; Renal Dialysis; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1981 |
Interaction between vancomycin and rifampin against Staphylococcus aureus.
Topics: Drug Interactions; Drug Therapy, Combination; Humans; Methicillin; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1981 |
Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts: report of three cases.
Topics: Aged; Cerebrospinal Fluid Shunts; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Meningitis; Rifampin; Staphylococcal Infections; Vancomycin | 1981 |
[Severe resistant staphylococcal infections. Treatment with a rifampicine-vancomycin combination].
Topics: Adult; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Rifampin; Staphylococcal Infections; Vancomycin | 1980 |
Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Cefamandole; Cephalothin; Endocarditis, Bacterial; Female; Gentamicins; Male; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1980 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Use of vancomycin for the treatment of Corynebacterium xerosis pneumonia.
Topics: Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Teicoplanin; Vancomycin | 1995 |
Pruritus associated with intravenous rifampin.
Topics: Female; Humans; Infusions, Intravenous; Middle Aged; Pruritus; Rifampin; Vancomycin | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Topics: Ampicillin; Animals; Aortic Valve; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1995 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
Enumeration of viable oral spirochetes from periodontal pockets.
Topics: Colony Count, Microbial; Culture Media; Dental Plaque; Humans; Microbial Sensitivity Tests; Periodontal Pocket; Polymyxins; Rifampin; Spectinomycin; Treponema; Vancomycin | 1994 |
Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.
Topics: Ceftriaxone; Drug Synergism; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Rifampin; Streptococcus pneumoniae; Tetracycline; Time Factors; Vancomycin | 1994 |
[Rhodococcus equi pneumonia in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Clarithromycin; Erythromycin; Humans; Imipenem; Male; Middle Aged; Pneumonia; Rhodococcus equi; Rifampin; Vancomycin | 1994 |
Combating drug-resistant pneumococcal infections.
Topics: Aged; Algorithms; Bacterial Vaccines; Cefotaxime; Cephalosporin Resistance; Chest Tubes; Combined Modality Therapy; Decision Trees; Diagnosis, Differential; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Penicillin Resistance; Pleural Effusion; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Rifampin; Streptococcus pneumoniae; Vancomycin | 1994 |
Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Colony Count, Microbial; Drug Therapy, Combination; Humans; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1994 |
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Drug Resistance, Microbial; Drug Therapy, Combination; Foreign-Body Reaction; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
In vitro antistaphylococcal activity of collagen-sealed Dacron vascular prostheses bonded with rifampin, vancomycin, or amikacin.
Topics: Amikacin; Blood Vessel Prosthesis; Collagen; Drug Delivery Systems; Immersion; Polyethylene Terephthalates; Prosthesis Design; Rifampin; Staphylococcus aureus; Surface Properties; Time Factors; Vancomycin | 1994 |
Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Ceftriaxone; Cerebrospinal Fluid; Cyclosporine; Dexamethasone; Drug Resistance, Microbial; Drug Therapy, Combination; Male; Meningitis, Pneumococcal; Penicillins; Rabbits; Rifampin; Vancomycin | 1994 |
Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm.
Topics: Bacterial Adhesion; Diffusion; Drug Implants; Drug Therapy, Combination; Models, Biological; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1993 |
A mouse model of implant-associated infection.
Topics: Animals; Catheterization; Catheters, Indwelling; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Peritoneal Cavity; Peritoneal Dialysis, Continuous Ambulatory; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1993 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Rifampin; Vancomycin | 1993 |
Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia.
Topics: Amikacin; Bacteremia; Chromatography, High Pressure Liquid; Drug Synergism; Drug Therapy, Combination; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1993 |
Pharmacokinetics and pharmacodynamics of antistaphylococcal antibiotics in continuous ambulatory peritoneal dialysis patients.
Topics: Anti-Bacterial Agents; Humans; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1993 |
Fatal encephalitis caused by concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi.
Topics: Adult; Drug Therapy, Combination; Encephalitis, Tick-Borne; Encephalomyelitis; Humans; Imipenem; Injections, Intravenous; Lyme Disease; Male; Polymerase Chain Reaction; Rifampin; Vancomycin | 1993 |
Staphylococcal meningitis can present as an abscess of a single lateral ventricle.
Topics: Adult; Brain Abscess; Cerebral Ventricles; Humans; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Nafcillin; Rifampin; Staphylococcal Infections; Tomography, X-Ray Computed; Vancomycin | 1993 |
Killing kinetics of vancomycin and rifampin tested alone and in combination against penicillin-resistant Streptococcus pneumoniae.
Topics: Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1993 |
Successful combination vancomycin and rifampin therapy in a newborn with community-acquired Flavobacterium meningosepticum neonatal meningitis.
Topics: Community-Acquired Infections; Drug Therapy, Combination; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Rifampin; Vancomycin | 1995 |
Antibiotics and prevention of microbial colonization of catheters.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Candida; Catheters, Indwelling; Clindamycin; Drug Synergism; Drug Therapy, Combination; Equipment Contamination; Minocycline; Novobiocin; Rifampin; Staphylococcus; Vancomycin | 1995 |
Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; England; Erythromycin; Humans; Penicillin Resistance; Pneumococcal Infections; Prevalence; Prospective Studies; Rifampin; Serotyping; Streptococcus pneumoniae; Vancomycin; Wales | 1996 |
Sensitization to acid induced by sodium ions in Escherichia coli: dependence of (p)ppGpp and cAMP and suppression of the relA-associated defect by mutations in envZ.
Topics: Bacterial Outer Membrane Proteins; Cyclic AMP; Erythromycin; Escherichia coli; Escherichia coli Proteins; Guanosine Tetraphosphate; Hydrochloric Acid; Hydrogen-Ion Concentration; Ligases; Multienzyme Complexes; Rifampin; Sodium Chloride; Suppression, Genetic; Vancomycin | 1996 |
The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
Topics: Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Clindamycin; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Philadelphia; Rifampin; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1995 |
Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or beta-lactam antibiotics against Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; beta-Lactams; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
[A case report of active aortic prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis].
Topics: Aged; Aneurysm, Infected; Anti-Bacterial Agents; Aortic Valve; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Heart Valve Prosthesis; Humans; Macrolides; Methicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1996 |
Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Blood Platelets; Colony Count, Microbial; Fibrin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Vancomycin | 1996 |
Efficacy of antibiotics alone for orthopaedic device related infections.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Minocycline; Prosthesis-Related Infections; Rabbits; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1996 |
Infective endocarditis caused by Streptococcus pneumoniae with high-level resistance to penicillin and cephalosporin.
Topics: Ceftriaxone; Cephalosporin Resistance; Endocarditis, Bacterial; Female; Humans; Middle Aged; Penicillin Resistance; Penicillins; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.
Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1997 |
The Etest for antimicrobial susceptibility testing of Bartonella henselae.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bartonella henselae; Cats; Ciprofloxacin; Doxycycline; Erythromycin; Humans; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1996 |
Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases.
Topics: Anti-Bacterial Agents; Child; Diagnosis, Differential; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Meningitis, Bacterial; Meningitis, Viral; Microbial Sensitivity Tests; Pneumococcal Infections; Rifampin; Vancomycin | 1997 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Evaluation of the in vitro activity of seven selected antimicrobial agents to be used for the isolation of human intestinal spirochaetes.
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antifungal Agents; Bacteriological Techniques; Child, Preschool; Colistin; Culture Media; Female; Humans; Intestinal Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Rifampin; Spectinomycin; Spiramycin; Spirochaetales; Vancomycin | 1997 |
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Levofloxacin; Mutation; Ofloxacin; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1996 |
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Evaluation Studies as Topic; Gentamicins; Glycopeptides; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Vancomycin | 1997 |
Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1997 |
Multidrug-resistant Pneumococcus causing vertebral osteomyelitis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteomyelitis; Pneumococcal Infections; Rifampin; Spinal Diseases; Streptococcus pneumoniae; Vancomycin | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
[Infections caused by beta-lactam resistant staphylococci on joint prostheses: diagnosis and treatment].
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Arthrodesis; beta-Lactam Resistance; Hip Prosthesis; Humans; Joint Prosthesis; Knee Prosthesis; Osteomyelitis; Prognosis; Prospective Studies; Prosthesis-Related Infections; Reoperation; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1997 |
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Naphthyridines; Novobiocin; Rifampin; Sulbactam; Teicoplanin; Vancomycin | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
In vitro anti-staphylococcal activity of heparinized biomaterials bonded with combinations of rifampicin.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cefuroxime; Collagen; Fusidic Acid; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1998 |
Colonic polyps and disseminated infection associated with Rhodococcus equi in a patient with AIDS.
Topics: Actinomycetales Infections; AIDS-Related Opportunistic Infections; Colonic Polyps; Drug Therapy, Combination; Humans; Lung; Male; Middle Aged; Rhodococcus equi; Rifampin; Vancomycin | 1998 |
Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
Topics: Aged; Doxycycline; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Rifampin; Vancomycin; Virginiamycin | 1998 |
Treatment options for chronic prostatitis due to vancomycin-resistant Enterococcus faecium.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chronic Disease; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Liver Transplantation; Male; Nitrofurantoin; Prostatitis; Rifampin; Urine; Vancomycin | 1998 |
Resistance of antibiotic-bonded gelatin-coated polymer meshes to Staphylococcus aureus in a rabbit subcutaneous pouch model.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Coated Materials, Biocompatible; Colony Count, Microbial; Drug Delivery Systems; Female; Gelatin; Gentamicins; Implants, Experimental; Microbial Sensitivity Tests; Polymers; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Surgical Mesh; Vancomycin | 1999 |
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Staphylococcus aureus; Sulbactam; Teicoplanin; Time Factors; Vancomycin; Virginiamycin | 1999 |
Septic arthritis caused by Corynebacterium amycolatum following vascular graft sepsis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Corynebacterium; Corynebacterium Infections; Doxycycline; Drug Therapy, Combination; Femoral Artery; Hip Joint; Humans; Male; Middle Aged; Osteoarthritis; Rifampin; Vancomycin | 1999 |
Adherent bacteria and activity of antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Drug Resistance, Microbial; Enzyme Inhibitors; Lactams; Mupirocin; Rifampin; Structure-Activity Relationship; Vancomycin | 1999 |
Identification of clinically isolated vancomycin-resistant enterococci: comparison of API and BBL Crystal systems.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Microbial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Reagent Kits, Diagnostic; Rifampin; Streptomycin; Vancomycin | 1999 |
Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biological Assay; Bone Transplantation; Cephalosporins; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Humans; Netilmicin; Penicillin G; Rifampin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 1999 |
Skp, a molecular chaperone of gram-negative bacteria, is required for the formation of soluble periplasmic intermediates of outer membrane proteins.
Topics: Bacterial Outer Membrane Proteins; Cell Membrane; DNA-Binding Proteins; Escherichia coli; Escherichia coli Proteins; Gene Deletion; Heat-Shock Proteins; Molecular Chaperones; Mutation; Novobiocin; Periplasm; Periplasmic Proteins; Protein Binding; Protein Folding; Rifampin; Serine Endopeptidases; Temperature; Vancomycin | 1999 |
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievab
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cephalosporin Resistance; Cephalosporins; Drug Interactions; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Streptococcus pneumoniae; Vancomycin | 1999 |
Comparative in vitro activity of vancomycin and levofloxacin in combination with rifampin against planktonic versus sessile cells of Staphylococcus epidermidis.
Topics: Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 2000 |
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Aza Compounds; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2000 |
Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
Topics: Animals; Anti-Bacterial Agents; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Methicillin; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Penicillins; Prevalence; Retrospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virulence | 2000 |
Foodborne listeriosis.
Topics: Adult; Anti-Bacterial Agents; Food Microbiology; Foodborne Diseases; Humans; Infant; Listeria monocytogenes; Listeriosis; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
[To avoid complications, treatment of meningitis should follow the guidelines and be reevaluated at 48 hours].
Topics: Acute Kidney Injury; Adult; Amoxicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Female; Guidelines as Topic; Humans; Meningitis, Pneumococcal; Penicillins; Rifampin; Time Factors; Vancomycin | 2000 |
A case of costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Infections; HIV-1; Humans; Male; Penicillins; Ribs; Rifampin; Tomography, X-Ray Computed; Vancomycin | 2000 |
Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Humans; Methicillin; Methicillin Resistance; Microscopy, Electron, Scanning; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin | 2001 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
Topics: Anti-Bacterial Agents; Cefotaxime; Child, Preschool; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Micrococcaceae; Neutropenia; Rifampin; Vancomycin | 2001 |
Prophylaxis against staphylococcal infection before tertiary knee joint replacement.
Topics: Antibiotic Prophylaxis; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Knee Joint; Middle Aged; Preoperative Care; Prosthesis Failure; Prosthesis-Related Infections; Recurrence; Reoperation; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2001 |
Nosocomial endocarditis caused by Corynebacterium amycolatum and other nondiphtheriae corynebacteria.
Topics: Aged; Catheters, Indwelling; Corynebacterium; Corynebacterium Infections; Cross Infection; Endocarditis, Bacterial; Fatal Outcome; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prosthesis-Related Infections; Rifampin; Vancomycin | 2002 |
An Escherichia coli mutant lacking the cold shock-induced palmitoleoyltransferase of lipid A biosynthesis: absence of unsaturated acyl chains and antibiotic hypersensitivity at 12 degrees C.
Topics: Acyltransferases; Carbohydrate Sequence; Cell Membrane; Cold Temperature; DNA; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Escherichia coli Proteins; Lipid A; Lipids; Mass Spectrometry; Molecular Sequence Data; Mutation; Plasmids; Promoter Regions, Genetic; Rifampin; Temperature; Time Factors; Vancomycin | 2002 |
Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
Topics: Animals; Brain Edema; Cerebrospinal Fluid; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Rifampin; Streptococcus pneumoniae; Time Factors; Vancomycin | 2002 |
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Joint Prosthesis; Methicillin Resistance; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Tissue Distribution; Vancomycin; Virginiamycin | 2002 |
Clinical, microbiological, and economic benefit of a change in antibiotic prophylaxis for cardiac surgery.
Topics: Administration, Oral; Anti-Bacterial Agents; Antibiotic Prophylaxis; Coronary Artery Bypass; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Rifampin; Surgical Wound Infection; Vancomycin | 2002 |
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study.
Topics: Adolescent; Age Distribution; Canada; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Incidence; Infant; Logistic Models; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Multivariate Analysis; Penicillin Resistance; Reference Values; Retrospective Studies; Rifampin; Risk Assessment; Sex Distribution; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2002 |
Effect of outer-membrane permeabilizers on the activity of antibiotics and plant extracts against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cell Membrane Permeability; Citrates; Drug Resistance, Bacterial; Edetic Acid; Erythromycin; Gentamicins; Muramidase; Phosphates; Plant Extracts; Pseudomonas aeruginosa; Rifampin; Sodium Citrate; Vancomycin | 2002 |
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Fusidic Acid; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus aureus; Vancomycin | 2003 |
[Rhône-Alpes observatory of Streptococcus pneumoniae in 1999: 35 cases of meningitis].
Topics: Adolescent; Adult; Aged; Amoxicillin; Cefotaxime; Child; Child, Preschool; Chloramphenicol; Drug Resistance, Microbial; Female; Fosfomycin; France; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Rifampin; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
Neonatal coagulase-negative staphylococcal meningitis: a report of two cases.
Topics: Antibiotics, Antitubercular; Coagulase; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Meningitis, Bacterial; Rifampin; Staphylococcal Infections; Staphylococcus; Treatment Outcome; Vancomycin | 2002 |
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Culture Media; Drug Combinations; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Oxazolidinones; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 2003 |
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Drug Tolerance; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance | 2003 |
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Glycopeptides; Implants, Experimental; Male; Microbial Sensitivity Tests; Oligopeptides; Polyethylene Terephthalates; Proteins; Rats; Rats, Wistar; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Subcutaneous Tissue; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2003 |
Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis.
Topics: Biofilms; Colony Count, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Polyurethanes; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Penicillins; Pennsylvania; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2004 |
[Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2003 |
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin | 2004 |
Progressive Staphylococcus lugdunensis endocarditis despite antibiotic treatment.
Topics: Abscess; Aged; Aorta, Thoracic; Aortic Valve; Cefuroxime; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Echocardiography, Transesophageal; Endocarditis, Bacterial; Humans; Male; Microbial Sensitivity Tests; Pericardial Effusion; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 2004 |
Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis.
Topics: Animals; Ceftriaxone; Colony Count, Microbial; Dexamethasone; Drug Evaluation, Preclinical; Drug Therapy, Combination; Meningitis, Pneumococcal; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin | 2004 |
Spontaneous corynebacterium discitis in a patient with chronic renal failure.
Topics: Anti-Bacterial Agents; Cephalosporins; Corynebacterium diphtheriae; Corynebacterium Infections; Diagnosis, Differential; Discitis; Diskectomy; Humans; Kidney Failure, Chronic; Low Back Pain; Lumbosacral Region; Magnetic Resonance Imaging; Male; Middle Aged; Rifampin; Vancomycin | 2004 |
Recurrent acute rheumatic fever: a forgotten diagnosis?
Topics: Acute Disease; Adult; Amoxicillin; Anti-Inflammatory Agents; Aortic Valve; Aortic Valve Insufficiency; Arthralgia; Bangladesh; Clarithromycin; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Emigration and Immigration; Endocarditis, Bacterial; England; Female; Fever; Gentamicins; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Penicillin G; Penicillin V; Pericarditis; Pharyngitis; Prednisone; Recurrence; Rheumatic Fever; Rheumatic Heart Disease; Rifampin; Unnecessary Procedures; Vancomycin | 2004 |
In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
Topics: Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kinetics; Methicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2004 |
Salvage of a prosthetic knee joint infected with resistant pneumococcus. A case report.
Topics: Aged; Anti-Infective Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Azithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Ofloxacin; Pneumococcal Infections; Prosthesis-Related Infections; Rifampin; Vancomycin | 2004 |
Polyurethanes loaded with antibiotics: influence of polymer-antibiotic interactions on in vitro activity against Staphylococcus epidermidis.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefamandole; Drug Interactions; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Polyurethanes; Rifampin; Staphylococcus epidermidis; Vancomycin | 2004 |
No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Liability, Legal; Linezolid; Methicillin Resistance; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2005 |
Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
Topics: Animals; Bone and Bones; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Minocycline; Osteomyelitis; Rabbits; Radiography; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin | 2005 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Identification of Lactobacillus ruminus SPM0211 isolated from healthy Koreans and its antimicrobial activity against some pathogens.
Topics: Adult; Base Sequence; Ciprofloxacin; DNA Fingerprinting; Drug Resistance, Bacterial; Enterococcus; Ethambutol; Feces; Humans; Korea; Lactobacillus; Microbial Sensitivity Tests; Molecular Sequence Data; Probiotics; Random Amplified Polymorphic DNA Technique; Rifampin; Staphylococcus aureus; Streptomycin; Time Factors; Vancomycin | 2005 |
Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Cerebrospinal Fluid; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Meningitis, Meningococcal; Penicillin Resistance; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin | 2005 |
Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
Topics: Animals; Ceftriaxone; Cephalosporin Resistance; Cerebrospinal Fluid; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Female; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Rifampin; Streptococcus pneumoniae; Vancomycin | 2005 |
Cortical allograft as a vehicle for antibiotic delivery.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bone Transplantation; Femur; Netilmicin; Postoperative Complications; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Transplantation, Homologous; Vancomycin | 2005 |
Paraneoplastic limbic encephalitis presenting as acute viral encephalitis.
Topics: Acute Disease; Acyclovir; Anti-Bacterial Agents; Anticonvulsants; Carcinoma, Renal Cell; Cerebrospinal Fluid; Diagnosis, Differential; Drug Therapy, Combination; Electroencephalography; Encephalitis, Viral; Enoxaparin; Ethambutol; Follow-Up Studies; Herpesvirus 1, Human; Humans; Isoniazid; Limbic Encephalitis; Limbic System; Magnetic Resonance Imaging; Male; Meningoencephalitis; Methylprednisolone; Middle Aged; Nephrectomy; Neuropsychological Tests; Paraneoplastic Syndromes, Nervous System; Phenytoin; Rifampin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2005 |
Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Genotype; Humans; Intensive Care Units; Methicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin Resistance; Polyethylene Terephthalates; Polytetrafluoroethylene; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2005 |
Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment.
Topics: Acetamides; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Linezolid; Meningitis, Bacterial; Methicillin Resistance; Middle Aged; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2006 |
Comparative in vitro efficacies of various catheter lock solutions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Candida albicans; Catheterization; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Edetic Acid; Ethanol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Pharmaceutical Preparations; Pseudomonas aeruginosa; Rifampin; Solutions; Staphylococcus aureus; Staphylococcus epidermidis; Taurine; Thiadiazines; Time Factors; Vancomycin | 2006 |
Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Female; Humans; Joint Prosthesis; Male; Methicillin Resistance; Middle Aged; Postoperative Period; Rifampin; Staphylococcal Infections; Vancomycin | 2006 |
Anterior mitral leaflet reconstruction with pericardium in a 1.9 kg infant with endocarditis.
Topics: Bioprosthesis; Birth Weight; Captopril; Combined Modality Therapy; Diseases in Twins; Diuretics; Endocarditis, Bacterial; Female; Gentamicins; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin Resistance; Mitral Valve; Mitral Valve Insufficiency; Pericardium; Rifampin; Staphylococcal Infections; Transplantation, Autologous; Twins, Monozygotic; Vancomycin | 2006 |
A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Clearance of Cellulosimicrobium cellulans bacteremia in a child without central venous catheter removal.
Topics: Actinomycetales; Actinomycetales Infections; Adolescent; Anti-Bacterial Agents; Bacteremia; Blood; Catheterization, Central Venous; Catheters, Indwelling; Drug Therapy, Combination; Humans; Male; Rifampin; Vancomycin | 2006 |
Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Blood Vessel Prosthesis; Ceftriaxone; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus; Vancomycin | 2006 |
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cloxacillin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Foreign-Body Reaction; Humans; Levofloxacin; Linezolid; Male; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Pharmacokinetics of intravenous rifampicin (rifampin) in neonates.
Topics: Area Under Curve; Bayes Theorem; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Infant, Newborn; Infusion Pumps; Infusions, Intravenous; Male; Metabolic Clearance Rate; Rifampin; Vancomycin | 2006 |
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Enzyme Inhibitors; Fosfomycin; Humans; In Vitro Techniques; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases.
Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Bacteremia; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Endocarditis, Bacterial; Female; Humans; Male; Methicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2007 |
Reactivation of dormant lumbar methicillin-resistant Staphylococcus aureus osteomyelitis after 12 years.
Topics: Abscess; Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Drug Therapy, Combination; Humans; Intervertebral Disc Displacement; Laminectomy; Linezolid; Lumbar Vertebrae; Male; Methicillin Resistance; Osteomyelitis; Oxazolidinones; Recurrence; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2007 |
Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
[Endocarditis in hemodialysis and prognosis].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Diabetes Complications; Discitis; Endocarditis, Bacterial; Fever; Heart Valve Prosthesis; Humans; Hyperparathyroidism, Secondary; Incidence; Kidney Failure, Chronic; Lumbar Vertebrae; Methicillin Resistance; Prognosis; Renal Dialysis; Rifampin; Spain; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Treatment of Staphylococcus aureus prosthetic valve endocarditis.
Topics: Aminoglycosides; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Daptomycin; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Molecular Sequence Data; Rifampin; Vancomycin; Vancomycin Resistance | 2007 |
Rhodococcus lung abscess complicating kidney transplantation: successful management by combination antibiotic therapy.
Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Transplantation; Lung Abscess; Male; Meropenem; Radiography; Rhodococcus equi; Rifampin; Sirolimus; Thienamycins; Treatment Outcome; Vancomycin | 2008 |
Deep sedation with intravenous infusion of combined propofol and ketamine during dressing changes and whirlpool bath in patients with severe epidermolysis bullosa.
Topics: Adolescent; Analgesics; Anesthetics, Intravenous; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bandages; Drug Therapy, Combination; Epidermolysis Bullosa; Female; Humans; Hydrotherapy; Infusions, Intravenous; Ketamine; Male; Pain; Propofol; Rifampin; Severity of Illness Index; Vancomycin; Wound Infection | 2007 |
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; Biological Evolution; Drug Resistance, Multiple; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Mutation; Phenotype; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation.
Topics: Actinomycetales Infections; Adolescent; Anti-Bacterial Agents; Ceftazidime; Cerebrospinal Fluid Shunts; Child; Cord Blood Stem Cell Transplantation; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunocompromised Host; Leukemia, Megakaryoblastic, Acute; Male; Meningitis, Bacterial; Meropenem; Micrococcaceae; Opportunistic Infections; Postoperative Complications; Rifampin; Sepsis; Thienamycins; Vancomycin | 2008 |
The bactericidal effects of anti-MRSA agents with rifampicin and sulfamethoxazole-trimethoprim against intracellular phagocytized MRSA.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Leukocytes, Mononuclear; Methicillin Resistance; Microbial Sensitivity Tests; Phagosomes; Rifampin; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2007 |
Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Biopsy; Colony Count, Microbial; Female; Mice; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Treatment Failure; Vancomycin | 2008 |
Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2008 |
Recognition and treatment of neonatal community-associated MRSA pneumonia and bacteremia.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Community-Acquired Infections; Drug Administration Schedule; Gentamicins; Humans; Infant, Newborn; Methicillin Resistance; Necrosis; Pneumonia, Staphylococcal; Rifampin; Staphylococcus aureus; Twins; Vancomycin | 2008 |
Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Kytococcus schroeteri: a probably underdiagnosed pathogen involved in prosthetic valve endocarditis.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Aortic Valve Insufficiency; DNA, Bacterial; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gentamicins; Heart Valve Prosthesis; Humans; Microbial Sensitivity Tests; Ofloxacin; Polymerase Chain Reaction; Rifampin; Vancomycin | 2008 |
Intravenous rifampicin for persistent staphylococcal bacteremia in premature infants.
Topics: Anti-Bacterial Agents; Bacteremia; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Male; Nucleic Acid Synthesis Inhibitors; Rifampin; Staphylococcal Infections; Vancomycin | 2008 |
Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valves; Kidney; Linezolid; Liver; Lung; Male; Methicillin Resistance; Microbial Sensitivity Tests; Microbial Viability; Models, Animal; Oxazolidinones; Plasma; Rabbits; Rifampin; Spleen; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin | 2008 |
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Genes, Bacterial; Gentamicins; Metronidazole; Microbial Sensitivity Tests; Mutation; Rifampin; Sulfamethoxazole; Vancomycin | 2008 |
Polyester vascular prostheses coated with a cyclodextrin polymer and activated with antibiotics: cytotoxicity and microbiological evaluation.
Topics: Anti-Bacterial Agents; Blood Vessel Prosthesis; Cell Survival; Cellulose; Ciprofloxacin; Cyclodextrins; Enterococcus; Escherichia coli; Humans; Microbial Sensitivity Tests; Polyesters; Prosthesis Design; Rifampin; Spectrophotometry; Staphylococcus aureus; Vancomycin | 2008 |
Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report.
Topics: Arthroplasty, Replacement; Biofilms; Combined Modality Therapy; Debridement; Device Removal; Diagnosis, Differential; Elbow Joint; Fractures, Ununited; Humans; Humeral Fractures; Internal Fixators; Male; Microscopy, Confocal; Middle Aged; Prosthesis Failure; Prosthesis-Related Infections; Radiography; Recurrence; Rifampin; Staphylococcal Infections; Vancomycin | 2008 |
Bacterial colonization of polymer brush-coated and pristine silicone rubber implanted in infected pockets in mice.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Mice; Mice, Inbred BALB C; Polymers; Prostheses and Implants; Rifampin; Silicone Elastomers; Staphylococcus aureus; Vancomycin | 2008 |
[Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus].
Topics: Aged; Bacteremia; Catheterization, Central Venous; Chronic Disease; Daptomycin; Discitis; Humans; Jugular Veins; Male; Methicillin-Resistant Staphylococcus aureus; Pancreatitis; Rifampin; Staphylococcal Infections; Vancomycin; Virginiamycin | 2008 |
Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteremia; Biofilms; Colony Count, Microbial; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Rifampin; Staphylococcal Infections; Tigecycline; Vancomycin | 2009 |
In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2008 |
Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses.
Topics: Animals; Anti-Bacterial Agents; Drug Implants; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus; Escherichia coli; Escherichia coli Infections; Male; Methicillin-Resistant Staphylococcus aureus; Minocycline; Penile Prosthesis; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2009 |
MRSA tricuspid valve infective endocarditis with multiple embolic lung abscesses treated by combination therapy of vancomycin, rifampicin, and sulfamethoxazole/trimethoprim.
Topics: Adult; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Lung Abscess; Methicillin-Resistant Staphylococcus aureus; Pregnancy; Pregnancy Complications, Infectious; Pulmonary Embolism; Rifampin; Staphylococcal Infections; Substance Abuse, Intravenous; Tricuspid Valve; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2009 |
[Treatment of mitral MRSA endocarditis using daptomycin].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Combined Modality Therapy; Daptomycin; Device Removal; Drug Therapy, Combination; Endocarditis, Bacterial; Fatal Outcome; Female; Gentamicins; Hip Prosthesis; Humans; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Postoperative Complications; Prosthesis-Related Infections; Respiratory Distress Syndrome; Rifampin; Staphylococcal Infections; Thrombocytopenia; Vancomycin | 2008 |
Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Guinea Pigs; Humans; Meningitis, Pneumococcal; Meropenem; Microbial Viability; Rifampin; Streptococcus pneumoniae; Thienamycins; Time Factors; Treatment Outcome; Vancomycin | 2009 |
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Endocarditis; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2009 |
Transconjunctival orbital invasion by methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Conjunctivitis; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Orbital Diseases; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2009 |
[Necrotising endocarditis of mitral valve due to Staphylococcus lugdunensis].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Chemotherapy, Adjuvant; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Necrosis; Rifampin; Staphylococcal Infections; Staphylococcus; Sulbactam; Ultrasonography; Vancomycin | 2009 |
Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Retrospective Studies; Rifampin; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Addition of rifampin to vancomycin for the treatment of pneumonias due to methicillin-resistant Staphylococcus aureus: caveat emptor.
Topics: Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Prognosis; Rifampin; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin | 2010 |
Bacteremia caused by a highly-resistant Streptococcus pneumoniae serotype 19A circulating in a daycare center.
Topics: Anti-Bacterial Agents; Bacteremia; Carrier State; Child Day Care Centers; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Israel; Pneumococcal Infections; Rifampin; Serotyping; Streptococcus pneumoniae; Vancomycin | 2010 |
Corynebacterium jeikeium bacteremia in a hemodialyzed patient.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Corynebacterium; Corynebacterium Infections; Female; Greece; Humans; Microbial Sensitivity Tests; Renal Dialysis; Rifampin; Skin; Vancomycin | 2010 |
Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis; Fatal Outcome; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Vancomycin | 2010 |
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Recurrence; Ribotyping; Rifampin; Severity of Illness Index; Vancomycin | 2010 |
[Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Topics: Anti-Bacterial Agents; Biofilms; Gentamicins; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Vancomycin | 2010 |
Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment.
Topics: Critical Care; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Rifampin; Risk Assessment; Treatment Outcome; Vancomycin | 2010 |
Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Synergism; Guinea Pigs; Microbial Sensitivity Tests; Polysaccharides, Bacterial; Rifampin; Staphylococcal Skin Infections; Staphylococcus epidermidis; Vancomycin; Virulence Factors | 2010 |
The risk of biomaterial-associated infection after revision surgery due to an experimental primary implant infection.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biofilms; Cross Infection; Equipment Contamination; Implants, Experimental; Mice; Prosthesis-Related Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bone and Bones; Bone Marrow; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Female; Joints; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rabbits; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Vancomycin | 2010 |
Infection rates of rifampin/gentamicin-coated Titan Coloplast penile implants. Comparison with Inhibizone-impregnated AMS penile implants.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Coated Materials, Biocompatible; Drug Therapy, Combination; Gentamicins; Humans; Male; Middle Aged; Minocycline; Penile Prosthesis; Prosthesis-Related Infections; Retrospective Studies; Rifampin; United States; Vancomycin | 2011 |
Farnesol as antibiotics adjuvant in Staphylococcus epidermidis control in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Farnesol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Microbial Viability; Plankton; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Stem Cells; Tetracycline; Time Factors; Vancomycin | 2011 |
Successful management of methicillin-resistant Staphylococcus aureus orbital cellulitis after blepharoplasty.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Blepharoplasty; Dexamethasone; Drug Therapy, Combination; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ophthalmic Solutions; Orbital Cellulitis; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
Topics: Anti-Bacterial Agents; Biofilms; Drug Interactions; Drug Therapy, Combination; Methicillin-Resistant Staphylococcus aureus; Models, Theoretical; Rifampin; Staphylococcal Infections; Vancomycin | 2011 |
Reduction in external ventricular drain infection rate. Impact of a minimal handling protocol and antibiotic-impregnated catheters.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Clindamycin; Coated Materials, Biocompatible; Cross Infection; Equipment Contamination; Humans; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin | 2011 |
Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.
Topics: Acetamides; Animals; Foreign Bodies; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Vancomycin | 2011 |
Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.
Topics: Aged; Agranulocytosis; Anti-Bacterial Agents; Cephalosporins; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Female; Humans; Rifampin; Syndrome; Vancomycin | 2011 |
[Curing a case of a pacemaker infection without removing it completely].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Biofilms; Combined Modality Therapy; Device Removal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrodes, Implanted; Endocarditis, Bacterial; Equipment Failure; Female; Humans; Pacemaker, Artificial; Postoperative Complications; Radiography, Interventional; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Ultrasonography; Vancomycin | 2011 |
Lactococcus garvieae causing zoonotic prosthetic valve endocarditis.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Fisheries; Gentamicins; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Lactococcus; Male; Middle Aged; Rifampin; Vancomycin; Zoonoses | 2011 |
Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Microbial Sensitivity Tests; Mutation; Rifampin; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2011 |
Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Foreign Bodies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Models, Animal; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tigecycline; Time Factors; Treatment Outcome; Vancomycin | 2011 |
Methicillin-resistant Staphylococcus aureus pelvic abscesses in a female after gynecologic pelvic surgery.
Topics: Abscess; Anti-Bacterial Agents; Female; Genital Diseases, Female; Gynecologic Surgical Procedures; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pelvic Organ Prolapse; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Rifampin; Tobramycin; Treatment Outcome; Vancomycin | 2011 |
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.
Topics: Anti-Infective Agents; Candida; Diabetic Foot; Doxycycline; Enterococcus; Enterococcus faecalis; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Rifampin; Staphylococcus aureus; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2011 |
Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Knee Prosthesis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Vancomycin | 2011 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Hepatorenal syndrome precipitated by infective endocarditis.
Topics: Aged; Anti-Bacterial Agents; Contraindications; Daptomycin; Disease Progression; Drug Substitution; Echocardiography, Transesophageal; Endocarditis; Fatal Outcome; Fluid Therapy; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Transplantation; Male; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin | 2011 |
Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anti-Bacterial Agents; beta-Cyclodextrins; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Ciprofloxacin; Coated Materials, Biocompatible; Dogs; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemolysis; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Platelet Aggregation; Prosthesis-Related Infections; Rifampin; Toxicity Tests; Treatment Outcome; Vancomycin; Wound Healing | 2012 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
[Mycobacterium massiliense bone infection].
Topics: Cicatrix; Clarithromycin; Debridement; Diabetes Mellitus, Type 2; Disease Susceptibility; Femoral Fractures; Fracture Fixation, Internal; Fractures, Closed; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Osteomyelitis; Osteotomy; Ribotyping; Rifampin; Surgical Wound Infection; Vancomycin | 2012 |
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin | 2012 |
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.
Topics: Anti-Bacterial Agents; Cell Line; Daptomycin; Gentamicins; Glycopeptides; Hemin; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitamin K 3 | 2012 |
Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin.
Topics: Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Farnesol; Fluorescent Dyes; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Rifampin; Staphylococcus epidermidis; Vancomycin | 2012 |
Kytococcus schroeteri prosthetic valve endocarditis.
Topics: Actinomycetales; Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Heart Valve Diseases; Humans; Male; Middle Aged; Prosthesis-Related Infections; Rifampin; Vancomycin | 2010 |
Does endocarditis require routine coagulation screening?
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Male; Rifampin; Vancomycin; Vitamin K Deficiency | 2010 |
Usefulness of SBA-15 mesoporous ceramics as a delivery system for vancomycin, rifampicin and linezolid: a preliminary report.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus subtilis; Biological Assay; Ceramics; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Linezolid; Micrococcaceae; Oxazolidinones; Rifampin; Silicon Dioxide; Vancomycin | 2012 |
Pyomyositis of the piriformis muscle presenting with sciatica in a teenage rugby player.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Floxacillin; Football; Humans; Low Back Pain; Magnetic Resonance Imaging; Male; Meropenem; Pain; Piriformis Muscle Syndrome; Pyomyositis; Rifampin; Sciatica; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 2012 |
Isolation and molecular characterization of methicillin-resistant staphylococci from horses, personnel and environmental sites at an equine hospital in Turkey.
Topics: Animal Technicians; Animals; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Genes, MDR; Horse Diseases; Horses; Humans; Methicillin Resistance; Polymerase Chain Reaction; Rifampin; Species Specificity; Staphylococcal Infections; Staphylococcus; Turkey; Vancomycin; Virginiamycin | 2012 |
[A case of MRSA infection in multiple artificial joints successfully treated with conservative medical treatment].
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Female; Humans; Knee Joint; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Titanium-tethered vancomycin prevents resistance to rifampicin in Staphylococcus aureus in vitro.
Topics: Anti-Bacterial Agents; Cells, Cultured; Coated Materials, Biocompatible; Drug Resistance, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Titanium; Vancomycin | 2012 |
Shunt-related intracranial abscess caused by Staphylococcus lugdunensis in a hydranencephalic patient.
Topics: Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Child, Preschool; Female; Humans; Hydranencephaly; Injections, Spinal; Neurosurgical Procedures; Rifampin; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Ventriculoperitoneal Shunt | 2013 |
Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.
Topics: Anti-Bacterial Agents; Bacteremia; Coagulase; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Male; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus; Treatment Outcome; Vancomycin | 2013 |
The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin-resistant Staphylococcus aureus USA400 in Rio de Janeiro, Brazil.
Topics: Adult; Anti-Bacterial Agents; Brazil; Echocardiography, Transesophageal; Endocarditis; Genotype; Health Facilities; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Molecular Typing; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Male; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Failure; Vancomycin | 2013 |
[Cerebritis and cerebral abscess due to Streptococcus pneumoniae in a newborn].
Topics: Anti-Bacterial Agents; Anticonvulsants; Bacteremia; Brain Abscess; Bronchiolitis; Cardiotonic Agents; Cerebral Hemorrhage; Drug Therapy, Combination; Fatal Outcome; Humans; Immunocompromised Host; Infant, Newborn; Magnetic Resonance Imaging; Male; Meningitis, Pneumococcal; Pneumococcal Infections; Respiratory Syncytial Virus Infections; Rifampin; Spleen; Streptococcus pneumoniae; Vancomycin | 2013 |
Maxillary sinusitis after sinus lift due to Gemella morbillorum: antibiotic and surgical treatment.
Topics: Anti-Bacterial Agents; Bone Transplantation; Drug Hypersensitivity; Endoscopy; Female; Follow-Up Studies; Gemella; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Maxillary Sinusitis; Middle Aged; Penicillins; Reoperation; Rifampin; Sinus Floor Augmentation; Surgical Wound Infection; Vancomycin | 2013 |
Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Prognosis; Rifampin; Staphylococcal Infections; Treatment Outcome; United Kingdom; Vancomycin; Young Adult | 2013 |
[Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Communicable Diseases, Emerging; Community-Acquired Infections; Endocarditis, Bacterial; Female; Gastrectomy; Genes, Bacterial; Gentamicins; Humans; Lymphoma, B-Cell, Marginal Zone; Methicillin-Resistant Staphylococcus aureus; Mitral Valve Insufficiency; Multiple Sclerosis; Neoplasms, Second Primary; Ovarian Neoplasms; Postoperative Complications; Rifampin; Staphylococcal Infections; Stomach Neoplasms; Vancomycin | 2013 |
Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Gentamicins; Horse Diseases; Horses; Macrolides; Microbial Sensitivity Tests; Mutation; Rhodococcus equi; Rifampin; Vancomycin | 2013 |
Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Genes, Bacterial; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2013 |
Identifying producers of antibacterial compounds by screening for antibiotic resistance.
Topics: Actinobacteria; Anti-Bacterial Agents; Biosynthetic Pathways; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Glycopeptides; Phylogeny; Reproducibility of Results; Rifampin; Vancomycin | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Peritonitis caused by Rothia mucilaginosa in a peritoneal dialysis patient.
Topics: Actinomycetales Infections; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Micrococcaceae; Peritoneal Dialysis; Peritonitis; Rifampin; Treatment Outcome; Vancomycin | 2013 |
[Septic cavernous sinus thrombosis following ethmoiditis: a case report].
Topics: Acute Disease; Cavernous Sinus; Cavernous Sinus Thrombosis; Combined Modality Therapy; Drug Therapy, Combination; Early Diagnosis; Ethmoid Sinus; Ethmoid Sinusitis; Facial Paralysis; Hemiplegia; Humans; Magnetic Resonance Imaging; Methicillin-Resistant Staphylococcus aureus; Physical Therapy Modalities; Rifampin; Staphylococcal Infections; Tomography, X-Ray Computed; Vancomycin | 2014 |
Stage 3 pyomyositis of the gluteus minimus; Staphylococcus aureus sepsis, autoanticoagulation, proximal femoral osteomyelitis and the role of surgical intervention.
Topics: Anti-Bacterial Agents; Buttocks; Delayed Diagnosis; Drainage; Humans; Male; Middle Aged; Muscle, Skeletal; Osteomyelitis; Pyomyositis; Rifampin; Sepsis; Staphylococcal Infections; Vancomycin | 2013 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Male; Mice; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2014 |
Antimicrobial synergism against different lineages of methicillin-resistant Staphylococcus aureus carrying SCCmec IV.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Biomass; Drug Synergism; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Rifampin; Vancomycin | 2014 |
[Vancomycin resistant Staphylococcus epidermidis caused prosthesis infection. Linezolid and rifampicin healed the complicated infection].
Topics: Acetamides; Anti-Bacterial Agents; Humans; Knee Prosthesis; Linezolid; Male; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
Antimicrobial effects of drug-containing electrospun matrices on osteomyelitis-associated pathogens.
Topics: Anti-Infective Agents; Biofilms; Drug Carriers; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Osteomyelitis; Rifampin; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2014 |
Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
Topics: Acetamides; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycopeptides; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2014 |
First case report of vancomycin-intermediate sequence type 72 Staphylococcus aureus with nonsusceptibility to daptomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Vancomycin | 2014 |
Unacylated tridecaptin A₁ acts as an effective sensitiser of Gram-negative bacteria to other antibiotics.
Topics: Anti-Bacterial Agents; Campylobacter jejuni; Cell Line; Cell Survival; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Lipopeptides; Microbial Sensitivity Tests; Peptides; Rifampin; Vancomycin | 2014 |
Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Child; Cross-Sectional Studies; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Health Care Surveys; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Practice Patterns, Physicians'; Rifampin; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Humans; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tigecycline; Vancomycin | 2015 |
Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Drug Interactions; Gentamicins; Humans; Microbial Viability; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 2015 |
Septic pulmonary and cerebral embolism caused by community-associated methicillin-resistant Staphylococcus aureus in a healthy child.
Topics: Adolescent; Anti-Bacterial Agents; Carbuncle; Community-Acquired Infections; Humans; Intracranial Embolism; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pulmonary Embolism; Rifampin; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Rifampicin resistance among multi-resistant MRSA clinical isolates from Chennai, India, and their molecular characterization.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; India; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Mutation; Phylogeny; Rifampin; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid; Staphylococcal Infections; Vancomycin | 2015 |
Combined local and systemic antibiotic treatment is effective against experimental Staphylococcus aureus peri-implant biofilm infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Female; Femur; Gentamicins; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Rifampin; Sepsis; Staphylococcal Infections; Stem Cells; Time Factors; Tobramycin; Vancomycin | 2015 |
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Topics: Anti-Bacterial Agents; Biofilms; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Half-Life; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2015 |
Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dog Diseases; Dogs; Lysostaphin; Methicillin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus; Thiazoles; Vancomycin | 2015 |
Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.
Topics: Anti-Bacterial Agents; Daptomycin; Microbial Sensitivity Tests; Mutation; Polymorphism, Single Nucleotide; Rifampin; Staphylococcus aureus; Vancomycin | 2015 |
Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Azithromycin; Bacterial Proteins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Lipid A; Lipopolysaccharides; Microbial Sensitivity Tests; Microbial Viability; Rifampin; Vancomycin | 2015 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Chest Pain and Shortness of Breath in a Previously Healthy Teenager.
Topics: Abscess; Adolescent; Allografts; Aorta; Aortic Rupture; Aortic Valve; Aortic Valve Insufficiency; Bicuspid Aortic Valve Disease; Cardiac Surgical Procedures; Chest Pain; Drug Resistance, Bacterial; Dyspnea; Endocarditis; Gentamicins; Heart Murmurs; Heart Valve Diseases; Humans; Male; Nafcillin; Pericardial Effusion; Rifampin; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Vascular Grafting | 2015 |
Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Drug Synergism; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Klebsiella Infections; Klebsiella pneumoniae; Mice, Inbred C57BL; Microbial Sensitivity Tests; Peptides; Rifampin; Vancomycin | 2015 |
New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Models, Biological; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
Poly(trimethylene carbonate) as a carrier for rifampicin and vancomycin to target therapy-recalcitrant staphylococcal biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Dioxanes; Drug Carriers; Drug Therapy, Combination; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymers; Rifampin; Vancomycin | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Bio-absorbable antibiotic impregnated beads for the treatment of prosthetic vascular graft infections.
Topics: Absorbable Implants; Academic Medical Centers; Aged; Anti-Bacterial Agents; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Debridement; Device Removal; Drug Carriers; Drug Combinations; Female; Gentamicins; Humans; Limb Salvage; Male; Middle Aged; Pennsylvania; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Editorial Commentary: Pyogenic Vertebral Osteomyelitis and Antimicrobial Therapy: It's Not Just the Length, but Also the Choice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Osteomyelitis; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Linezolid; Mice; Microbial Sensitivity Tests; Osteomyelitis; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.
Topics: Anti-Bacterial Agents; Bacteremia; Child, Preschool; Daptomycin; Endocarditis, Bacterial; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Antimicrobial susceptibility of Vibrio alginolyticus isolated from oyster in Korea.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cephalothin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Ostreidae; Republic of Korea; Rifampin; Shellfish; Vancomycin; Vibrio alginolyticus | 2016 |
Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bone Wires; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Foreign Bodies; Injections, Intraperitoneal; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Osteomyelitis; Oxazoles; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tibia; Vancomycin | 2016 |
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Aztreonam; Bacteremia; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Rifampin; Teicoplanin; Thienamycins; Vancomycin | 2016 |
A Standardized Regimen for the Treatment of Acute Postoperative Infections and Acute Hematogenous Infections Associated With Hip and Knee Arthroplasties.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bacteremia; Clinical Protocols; Debridement; Female; Humans; Male; Middle Aged; Postoperative Period; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Rifampin; Therapeutic Irrigation; Treatment Outcome; Vancomycin | 2017 |
3D scaffold with effective multidrug sequential release against bacteria biofilm.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Biofilms; Body Fluids; Calcification, Physiologic; Cell Line; Drug Liberation; Kinetics; Levofloxacin; Mice; Microbial Sensitivity Tests; Osteoblasts; Rifampin; Tissue Scaffolds; Vancomycin; X-Ray Diffraction | 2017 |
Rifampin-Based Combination Therapy Is Active in Foreign-Body Osteomyelitis after Prior Rifampin Monotherapy.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Foreign Bodies; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Rats, Wistar; Rifampin; Staphylococcal Infections; Vancomycin | 2017 |
Successful treatment of methicillin-resistant Staphylococcus aureus infection associated with Jones tube using vancomycin eye drops and rifampicin.
Topics: Aged; Anti-Bacterial Agents; Biofilms; Dacryocystorhinostomy; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Intubation; Lacrimal Duct Obstruction; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Ophthalmic Solutions; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Antibacterial effect of antibiotic-loaded SBA-15 on biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Bacterial Load; Biocompatible Materials; Biofilms; Ceramics; Drug Combinations; Drug Delivery Systems; Microbial Sensitivity Tests; Rifampin; Silicon Dioxide; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2017 |
Effect of a standardized treatment regime for infection after osteosynthesis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clinical Protocols; Combined Modality Therapy; Debridement; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fracture Fixation, Internal; Fractures, Bone; Humans; Male; Middle Aged; Osteomyelitis; Prosthesis Retention; Retrospective Studies; Rifampin; Surgical Wound Infection; Trauma Centers; Vancomycin; Young Adult | 2017 |
Simkania negevensis, an Example of the Diversity of the Antimicrobial Susceptibility Pattern among Chlamydiales.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cell Line; Chlamydiaceae Infections; Chlamydiales; Chlorocebus aethiops; Clindamycin; Macrolides; Microbial Sensitivity Tests; Quinolones; Rifampin; Vancomycin; Vero Cells | 2017 |
In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Biofilms; Catheter-Related Infections; Catheters; Drug Resistance, Bacterial; Egypt; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Polymerase Chain Reaction; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Tertiary Care Centers; Vancomycin | 2017 |
Vascular Graft Impregnation with Antibiotics: The Influence of High Concentrations of Rifampin, Vancomycin, Daptomycin, and Bacteriophage Endolysin HY-133 on Viability of Vascular Cells.
Topics: Anti-Bacterial Agents; Cell Survival; Daptomycin; Endopeptidases; Endothelial Cells; Fibroblasts; Humans; Microbial Sensitivity Tests; Muscle, Smooth, Vascular; Rifampin; Vancomycin; Vascular Grafting | 2017 |
How do fluorescence spectroscopy and multimodal fluorescence imaging help to dissect the enhanced efficiency of the vancomycin-rifampin combination against Staphylococcus aureus infections?
Topics: Anti-Bacterial Agents; Biofilms; Microbial Sensitivity Tests; Optical Imaging; Rifampin; Spectrometry, Fluorescence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Neurosurgical Procedures; Pneumonia, Ventilator-Associated; Rifampin; Subarachnoid Hemorrhage; Vancomycin | 2017 |
Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Carriers; Fractures, Open; Polymethyl Methacrylate; Rats; Rats, Inbred Lew; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wound Infection | 2017 |
Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Bacterial Proteins; Cell Wall; Drug Resistance, Multiple, Bacterial; Ethambutol; Galactans; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Ion Pumps; Isoniazid; Ligases; Mannosyltransferases; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Peptidoglycan; Rifampin; Serine Proteases; Thienamycins; Vancomycin | 2017 |
The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Tolerance; Ethambutol; Gene Expression Regulation, Bacterial; Gentamicins; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sigma Factor; Streptomycin; Vancomycin | 2017 |
Polymyxin B
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Polymyxins; Pseudomonas aeruginosa; Rifampin; Tobramycin; Vancomycin | 2017 |
Dalbavancin treatment in a deep sternal wound MRSA infection after coronary artery bypass surgery: a case report.
Topics: Anti-Bacterial Agents; Coronary Artery Bypass; Debridement; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; ST Elevation Myocardial Infarction; Staphylococcal Infections; Sternum; Surgical Wound Infection; Teicoplanin; Vancomycin | 2018 |
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Spontaneous methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Aspirin; Cerebellum; Female; Humans; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Prednisone; Rifampin; Risk Factors; Severity of Illness Index; Staphylococcal Infections; Vancomycin; Young Adult | 2018 |
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
Topics: Aged; Anti-Bacterial Agents; Cloxacillin; Endocarditis, Bacterial; Female; Gentamicins; Heart Failure; Heart Valve Prosthesis; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Prosthesis-Related Infections; Renal Insufficiency; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2018 |
Topical rifampin powder for orthopedic trauma part I: Rifampin powder reduces recalcitrant infection in a delayed treatment musculoskeletal trauma model.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Musculoskeletal System; Polymethyl Methacrylate; Powders; Rats; Rats, Inbred Lew; Rifampin; Staphylococcal Infections; Time-to-Treatment; Vancomycin | 2018 |
Resuscitation-Promoting Factors Are Required for Mycobacterium smegmatis Biofilm Formation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cell Wall; Cytokines; Gene Deletion; Microbial Sensitivity Tests; Muramic Acids; Mycobacterium smegmatis; Peptidoglycan; Rifampin; RNA, Messenger; Sodium Dodecyl Sulfate; Vancomycin | 2018 |
Purulent pericarditis secondary to influenza and community-acquired methicillin-resistant Staphylococcus aureus co-infection.
Topics: Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Humans; Influenza B virus; Influenza, Human; Male; Methicillin-Resistant Staphylococcus aureus; Pericarditis; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2018 |
Topical rifampin powder for orthopaedic trauma part II: Topical rifampin allows for spontaneous bone healing in sterile and contaminated wounds.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Fracture Healing; Musculoskeletal System; Orthopedic Procedures; Osteogenesis; Powders; Rats; Rats, Sprague-Dawley; Rifampin; Surgical Wound Infection; Vancomycin | 2018 |
Staphylococcus aureus at an Indian tertiary hospital: Antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; India; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tertiary Care Centers; Vancomycin | 2019 |
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin | 2019 |
Desferrioxamine:gallium-pluronic micelles increase outer membrane permeability and potentiate antibiotic activity against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cell Membrane Permeability; Deferoxamine; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Escherichia coli; Gallium; HeLa Cells; Humans; Micelles; Microbial Sensitivity Tests; Poloxamer; Pseudomonas aeruginosa; Rifampin; Surface-Active Agents; Vancomycin | 2018 |
Multispacer sequence typing of Coxiella burnetii DNA from removed prosthetic heart valve material discloses first human case of infective endocarditis caused by MST_18.
Topics: Abscess; Aged; Aortic Valve; Coxiella burnetii; Denmark; DNA, Bacterial; Doxycycline; Echinocandins; Endocarditis, Bacterial; Fatal Outcome; Gentamicins; Heart Valve Prosthesis; Humans; Male; Meropenem; Metronidazole; Multilocus Sequence Typing; Rifampin; RNA, Ribosomal, 16S; Vancomycin | 2019 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Empirical Research; Enterobacteriaceae; Female; Gene Expression; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Spine; Streptococcus; Vancomycin | 2019 |
In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Rifampin; Vancomycin | 2019 |
Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.
Topics: Adenosine; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Prosthesis-Related Infections; Pseudomonas aeruginosa; Purinergic P2Y Receptor Antagonists; Rifampin; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Ticagrelor; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Edetic Acid; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Rifampin; Species Specificity; Vancomycin | 2019 |
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genes, Bacterial; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Rifampin; Staphylococcal Infections; Tetracycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2020 |
Effect of tolerance on the evolution of antibiotic resistance under drug combinations.
Topics: Anti-Bacterial Agents; Daptomycin; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Therapy, Combination; Evolution, Molecular; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Polymorphism, Single Nucleotide; Rifampin; Staphylococcal Infections; Vancomycin | 2020 |
Early neonatal sepsis and meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Rifampin; Saudi Arabia; Sepsis; Treatment Outcome; Vancomycin | 2020 |
Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Cephalosporins; Cross-Sectional Studies; Drug Therapy, Combination; Fluconazole; Heart-Assist Devices; Humans; Levofloxacin; Prosthesis Implantation; Prosthesis-Related Infections; Rifampin; Surgical Wound Infection; Surveys and Questionnaires; Vancomycin | 2020 |
Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Foreign Bodies; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rats; Rats, Wistar; Rifabutin; Rifampin; Staphylococcal Infections; Vancomycin | 2020 |
A case report of the differential diagnosis of Cellulosimicrobium cellulans-infected endocarditis combined with intracranial infection by conventional blood culture and second-generation sequencing.
Topics: Actinobacteria; Actinomycetales Infections; Blood Culture; Diagnosis, Differential; Endocarditis; Fatal Outcome; Female; Humans; Middle Aged; Rifampin; Sequence Analysis, DNA; Vancomycin | 2020 |
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Salvage Therapy; Standard of Care; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
Topics: Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2021 |
In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus.
Topics: Agar; Anti-Bacterial Agents; Biofilms; Drug Synergism; Glycopeptides; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Microscopy, Fluorescence; Polyethylene; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Stem Cells; Teicoplanin; Vancomycin | 2021 |
Prevention, inhibition, and degradation effects of melittin alone and in combination with vancomycin and rifampin against strong biofilm producer strains of methicillin-resistant Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Genes, Bacterial; HEK293 Cells; Humans; Melitten; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Vancomycin | 2022 |
Real time monitoring of Staphylococcus aureus biofilm sensitivity towards antibiotics with isothermal microcalorimetry.
Topics: Anti-Bacterial Agents; Biofilms; Calorimetry; Floxacillin; Genetic Linkage; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Vancomycin | 2022 |
Halicin Is Effective Against Staphylococcus aureus Biofilms In Vitro.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefazolin; Mice; Microbial Sensitivity Tests; Reproducibility of Results; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Thiadiazoles; Tobramycin; Vancomycin | 2022 |
Topics: Agar; Anti-Bacterial Agents; Bacteria; Calcium Sulfate; Diabetes Mellitus; Diabetic Foot; Floxacillin; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2022 |
Enhancement of Impaired MRSA-Infected Fracture Healing by Combinatorial Antibiotics and Modulation of Sustained Inflammation.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Femoral Fractures; Fracture Healing; Inflammation; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Rifampin; Staphylococcal Infections; Vancomycin; X-Ray Microtomography | 2022 |
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ciprofloxacin; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Retrospective Studies; Rifampin; Treatment Outcome; Vancomycin | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Biofilms; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Teicoplanin; Vancomycin | 2022 |
Common Pathogens and Drug Resistance of Neonatal Pneumonia with New Multichannel Sensor.
Topics: Chloramphenicol; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Infant, Newborn; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Erythromycin; Gram-Negative Bacteria; Linezolid; Lipid A; Novobiocin; Oxazolidinones; Rifampin; Vancomycin | 2022 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Vancomycin | 2023 |
Nosocomial meningitis caused by Staphylococcus haemolyticus in a child with neutropenia in the absence of intracranial devices: a case report.
Topics: Adolescent; Anti-Bacterial Agents; Child; Coagulase; Cross Infection; Hospitals; Humans; Linezolid; Male; Meningitis, Bacterial; Neutropenia; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus haemolyticus; Vancomycin | 2023 |
Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin.
Topics: Anti-Bacterial Agents; Biofilms; Biological Availability; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Vancomycin | 2023 |
Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus epidermidis; Vancomycin | 2023 |
Fibrinolytic and antibiotic treatment of prosthetic vascular graft infections in a novel rat model.
Topics: Animals; Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus aureus; Prosthesis-Related Infections; Rats; Rifampin; Staphylococcal Infections; Tissue Plasminogen Activator; Vancomycin | 2023 |
The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Linezolid; Pentamidine; Reactive Oxygen Species; Rifampin; Tetracycline; Vancomycin | 2023 |